| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.728 | 0.005 | 0.736 | 5 Hydroxytryptamine release stimulant | 0.736 0.005 CID_996 | CID_996 | |
| 0.727 | 0.006 | 0.88 | Aldehyde oxidase inhibitor | 0.88 0.004 CID_996 | CID_996 | |
| 0.699 | 0.003 | 0.699 | Alpha-N-acetylglucosaminidase inhibitor | 0.61 0.004 CID_996 | ||
| 0.682 | 0.004 | 0.702 | GABA C receptor rho-3 antagonist | 0.702 0.003 CID_996 | CID_996 | |
| 0.658 | 0.003 | 0.873 | Alcohol oxidase inhibitor | 0.873 0.002 CID_996 | CID_996 | |
| 0.653 | 0.029 | 0.747 | Caspase 9 stimulant | 0.747 0.018 CID_996 | CID_996 | |
| 0.616 | 0.004 | 0.729 | Peroxidase inhibitor | 0.729 0.003 CID_996 | CID_996 | |
| 0.597 | 0.003 | 0.597 | GABA C receptor agonist | 0.544 0.003 CID_996 | ||
| 0.603 | 0.01 | 0.627 | 5 Hydroxytryptamine release inhibitor | 0.627 0.008 CID_996 | CID_996 | |
| 0.594 | 0.008 | 0.594 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.504 0.032 CID_996 | ||
| 0.56 | 0.011 | 0.584 | Calcium channel L-type activator | 0.584 0.008 CID_996 | CID_996 | |
| 0.556 | 0.009 | 0.658 | Superoxide dismutase inhibitor | 0.658 0.005 CID_996 | CID_996 | |
| 0.527 | 0.004 | 0.527 | 5 Hydroxytryptamine uptake stimulant | 0.521 0.004 CID_996 | ||
| 0.501 | 0.004 | 0.653 | Tyrosine 3 hydroxylase inhibitor | 0.653 0.003 CID_996 | CID_996 | |
| 0.512 | 0.025 | 0.564 | Histamine release inhibitor | 0.564 0.014 CID_996 | CID_996 | |
| 0.462 | 0.003 | 0.462 | Ferrochelatase inhibitor | 0.342 0.005 CID_996 | ||
| 0.493 | 0.034 | 0.572 | Cholesterol antagonist | 0.572 0.022 CID_996 | CID_996 | |
| 0.464 | 0.013 | 0.464 | Sigma receptor agonist | 0.356 0.029 CID_996 | ||
| 0.458 | 0.01 | 0.458 | Calcium channel activator | 0.447 0.012 CID_996 | ||
| 0.448 | 0.004 | 0.542 | Porphobilinogen synthase inhibitor | 0.542 0.003 CID_996 | CID_996 | |
| 0.451 | 0.04 | 0.456 | Vasodilator, peripheral | 0.456 0.039 CID_996 | CID_996 | |
| 0.419 | 0.014 | 0.45 | Anesthetic general | 0.45 0.011 CID_996 | CID_996 | |
| 0.398 | 0.006 | 0.404 | UDP-glucose 4-epimerase inhibitor | 0.404 0.005 CID_996 | CID_996 | |
| 0.385 | 0.004 | 0.385 | Triose-phosphate isomerase inhibitor | 0.352 0.004 CID_996 | ||
| 0.382 | 0.004 | 0.407 | Succinate dehydrogenase inhibitor | 0.407 0.004 CID_996 | CID_996 | |
| 0.389 | 0.019 | 0.401 | RNA-directed DNA polymerase inhibitor | 0.401 0.018 CID_996 | CID_996 | |
| 0.369 | 0.004 | 0.369 | GABA C receptor rho-2 antagonist | 0.361 0.004 CID_996 | ||
| 0.414 | 0.051 | 0.414 | MAP kinase kinase 6 inhibitor | |||
| 0.365 | 0.004 | 0.365 | GABA C receptor antagonist | 0.345 0.004 CID_996 | ||
| 0.364 | 0.004 | 0.364 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.314 0.005 CID_996 | ||
| 0.368 | 0.024 | 0.368 | Interleukin agonist | 0.356 0.027 CID_996 | ||
| 0.338 | 0.005 | 0.356 | Nitric-oxide synthase stimulant | 0.356 0.005 CID_996 | CID_996 | |
| 0.331 | 0.004 | 0.331 | 5 Hydroxytryptamine 3E antagonist | 0.27 0.009 CID_996 | ||
| 0.373 | 0.045 | 0.379 | Vasodilator, coronary | 0.379 0.042 CID_996 | CID_996 | |
| 0.34 | 0.014 | 0.389 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.389 0.009 CID_996 | CID_996 | |
| 0.327 | 0.006 | 0.327 | NADH dehydrogenase inhibitor | 0.322 0.006 CID_996 | ||
| 0.352 | 0.033 | 0.365 | Insulysin inhibitor | 0.365 0.029 CID_996 | CID_996 | |
| 0.333 | 0.015 | 0.333 | Gastrin inhibitor | 0.294 0.037 CID_996 | ||
| 0.319 | 0.006 | 0.319 | Adenylate kinase inhibitor | 0.281 0.008 CID_996 | ||
| 0.383 | 0.071 | 0.383 | Calpain 2 inhibitor | 0.33 0.096 CID_996 | ||
| 0.341 | 0.032 | 0.354 | DNA synthesis inhibitor | 0.354 0.029 CID_996 | CID_996 | |
| 0.355 | 0.049 | 0.397 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.397 0.039 CID_996 | CID_996 | |
| 0.307 | 0.004 | 0.467 | Creatine kinase inhibitor | 0.467 0.002 CID_996 | CID_996 | |
| 0.311 | 0.009 | 0.489 | Cystathionine beta-synthase inhibitor | 0.489 0.004 CID_996 | CID_996 | |
| 0.302 | 0.003 | 0.302 | GABA C receptor rho-1 antagonist | 0.277 0.004 CID_996 | ||
| 0.328 | 0.032 | 0.331 | Cyclic AMP phosphodiesterase inhibitor | 0.331 0.031 CID_996 | CID_996 | |
| 0.295 | 0.005 | 0.295 | Mannose-6-phosphate isomerase inhibitor | 0.29 0.006 CID_996 | ||
| 0.312 | 0.023 | 0.312 | 5 Hydroxytryptamine 1E antagonist | 0.305 0.027 CID_996 | ||
| 0.299 | 0.012 | 0.299 | 3C-like protease (Human coronavirus) inhibitor | 0.259 0.024 CID_996 | ||
| 0.3 | 0.018 | 0.375 | Neurotrophic factor enhancer | 0.375 0.007 CID_996 | CID_996 | |
| 0.288 | 0.01 | 0.288 | MAP kinase kinase 3 inhibitor | |||
| 0.284 | 0.007 | 0.399 | Histidine decarboxylase inhibitor | 0.399 0.004 CID_996 | CID_996 | |
| 0.33 | 0.053 | 0.341 | Aryl hydrocarbon receptor agonist | 0.341 0.05 CID_996 | CID_996 | |
| 0.278 | 0.004 | 0.418 | Phenylalanine 4-hydroxylase inhibitor | 0.418 0.003 CID_996 | CID_996 | |
| 0.307 | 0.041 | 0.307 | Psychostimulant | 0.292 0.045 CID_996 | ||
| 0.279 | 0.014 | 0.374 | Aldehyde dehydrogenase inhibitor | 0.374 0.006 CID_996 | CID_996 | |
| 0.285 | 0.02 | 0.399 | Amylase inhibitor | 0.399 0.009 CID_996 | CID_996 | |
| 0.269 | 0.004 | 0.269 | 5 Hydroxytryptamine 3A agonist | 0.252 0.005 CID_996 | ||
| 0.308 | 0.051 | 0.342 | Transcription factor STAT inhibitor | 0.342 0.037 CID_996 | CID_996 | |
| 0.257 | 0.004 | 0.257 | Biliverdin reductase inhibitor | 0.188 0.006 CID_996 | ||
| 0.274 | 0.021 | 0.386 | Phospholipase C inhibitor | 0.386 0.011 CID_996 | CID_996 | |
| 0.296 | 0.049 | 0.387 | Pyruvate kinase inhibitor | 0.387 0.023 CID_996 | CID_996 | |
| 0.251 | 0.005 | 0.251 | Electrolyte absorption antagonist | 0.193 0.009 CID_996 | ||
| 0.255 | 0.012 | 0.326 | Carbonic anhydrase XV inhibitor | 0.326 0.006 CID_996 | CID_996 | |
| 0.295 | 0.056 | 0.322 | Transcription factor STAT3 inhibitor | 0.322 0.043 CID_996 | CID_996 | |
| 0.296 | 0.058 | 0.307 | DNA damaging | 0.307 0.054 CID_996 | CID_996 | |
| 0.279 | 0.042 | 0.279 | MAP kinase kinase 2 inhibitor | 0.262 0.049 CID_996 | ||
| 0.242 | 0.008 | 0.242 | Phosphofructokinase-1 inhibitor | 0.24 0.008 CID_996 | ||
| 0.26 | 0.027 | 0.26 | Cytidine deaminase inhibitor | 0.207 0.044 CID_996 | ||
| 0.236 | 0.006 | 0.252 | HIV-1 integrase (Overall Integration) inhibitor | 0.252 0.005 CID_996 | CID_996 | |
| 0.244 | 0.015 | 0.251 | ATPase inhibitor | 0.251 0.013 CID_996 | CID_996 | |
| 0.268 | 0.04 | 0.268 | Neuropeptide Y2 antagonist | 0.268 0.04 CID_996 | ||
| 0.235 | 0.008 | 0.235 | Glutamate dehydrogenase inhibitor | 0.214 0.009 CID_996 | ||
| 0.235 | 0.009 | 0.273 | CF transmembrane conductance regulator agonist | 0.273 0.005 CID_996 | CID_996 | |
| 0.308 | 0.083 | 0.326 | Antithrombotic | 0.326 0.074 CID_996 | CID_996 | |
| 0.294 | 0.069 | 0.294 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.218 0.137 CID_996 | ||
| 0.268 | 0.044 | 0.268 | ErbB-1 antagonist | 0.249 0.052 CID_996 | ||
| 0.227 | 0.003 | 0.227 | Aconitate hydratase inhibitor | 0.168 0.004 CID_996 | ||
| 0.234 | 0.01 | 0.24 | Arachidonic acid antagonist | 0.24 0.008 CID_996 | CID_996 | |
| 0.333 | 0.109 | 0.454 | 15-Lipoxygenase inhibitor | 0.454 0.053 CID_996 | CID_996 | |
| 0.25 | 0.026 | 0.398 | NOS3 expression enhancer | 0.398 0.008 CID_996 | CID_996 | |
| 0.228 | 0.005 | 0.314 | Glutamate decarboxylase inhibitor | 0.314 0.003 CID_996 | CID_996 | |
| 0.228 | 0.006 | 0.228 | Carbamoyl phosphate synthetase inhibitor | 0.193 0.008 CID_996 | ||
| 0.308 | 0.09 | 0.434 | Transcription factor NF kappa B inhibitor | 0.434 0.056 CID_996 | CID_996 | |
| 0.247 | 0.029 | 0.301 | Interferon gamma antagonist | 0.301 0.02 CID_996 | CID_996 | |
| 0.223 | 0.006 | 0.262 | Prolactin inhibitor | 0.262 0.004 CID_996 | CID_996 | |
| 0.227 | 0.012 | 0.342 | Carbonic anhydrase III inhibitor | 0.342 0.005 CID_996 | CID_996 | |
| 0.222 | 0.007 | 0.245 | Adenylate cyclase stimulant | 0.245 0.004 CID_996 | CID_996 | |
| 0.218 | 0.006 | 0.218 | CYP2A6 inhibitor | 0.149 0.017 CID_996 | ||
| 0.295 | 0.083 | 0.419 | 12-Lipoxygenase inhibitor | 0.419 0.034 CID_996 | CID_996 | |
| 0.233 | 0.021 | 0.267 | Hexokinase inhibitor | 0.267 0.014 CID_996 | CID_996 | |
| 0.264 | 0.053 | 0.264 | Calpain inhibitor | 0.245 0.07 CID_996 | ||
| 0.217 | 0.01 | 0.219 | Photosensitizer | 0.219 0.009 CID_996 | CID_996 | |
| 0.238 | 0.031 | 0.238 | Histone acetyltransferase inhibitor | 0.232 0.035 CID_996 | ||
| 0.212 | 0.006 | 0.212 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.167 0.008 CID_996 | ||
| 0.211 | 0.005 | 0.211 | Acyl-CoA dehydrogenase inhibitor | 0.165 0.008 CID_996 | ||
| 0.283 | 0.077 | 0.322 | Spasmolytic | 0.322 0.062 CID_996 | CID_996 | |
| 0.218 | 0.014 | 0.218 | Nav1.6 sodium channel blocker | 0.181 0.028 CID_996 | ||
| 0.25 | 0.047 | 0.286 | DNA methyltransferase I inhibitor | 0.286 0.031 CID_996 | CID_996 | |
| 0.221 | 0.018 | 0.221 | Cathepsin H inhibitor | 0.189 0.026 CID_996 | ||
| 0.208 | 0.005 | 0.274 | DOPA decarboxylase inhibitor | 0.274 0.003 CID_996 | CID_996 | |
| 0.207 | 0.005 | 0.207 | Glutamate release inhibitor | 0.181 0.005 CID_996 | ||
| 0.209 | 0.007 | 0.209 | Argininosuccinate synthase inhibitor | 0.177 0.009 CID_996 | ||
| 0.205 | 0.003 | 0.205 | Ca2+-transporting ATPase inhibitor | 0.201 0.003 CID_996 | ||
| 0.279 | 0.077 | 0.371 | Hypoxia-inducible factor 1 alpha inhibitor | 0.371 0.038 CID_996 | CID_996 | |
| 0.227 | 0.026 | 0.299 | NADPH oxidase inhibitor | 0.299 0.013 CID_996 | CID_996 | |
| 0.212 | 0.013 | 0.212 | Catalase inhibitor | 0.203 0.015 CID_996 | ||
| 0.241 | 0.042 | 0.241 | I kappa B kinase epsilon inhibitor | 0.225 0.052 CID_996 | ||
| 0.216 | 0.018 | 0.216 | Aminopeptidase B inhibitor | 0.214 0.018 CID_996 | ||
| 0.221 | 0.023 | 0.228 | Cell wall synthesis inhibitor | 0.228 0.021 CID_996 | CID_996 | |
| 0.269 | 0.074 | 0.269 | Ca(v)3.3 blocker | |||
| 0.255 | 0.06 | 0.255 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.245 | 0.051 | 0.274 | DNA methylase inhibitor | 0.274 0.037 CID_996 | CID_996 | |
| 0.317 | 0.123 | 0.375 | Antibacterial | 0.375 0.089 CID_996 | CID_996 | |
| 0.281 | 0.089 | 0.465 | Caspase 3 stimulant | 0.465 0.026 CID_996 | CID_996 | |
| 0.202 | 0.011 | 0.202 | Sphingosine 1-phosphate receptor 5 antagonist | 0.197 0.013 CID_996 | ||
| 0.219 | 0.028 | 0.39 | M18 aspartyl aminopeptidase inhibitor | 0.39 0.005 CID_996 | CID_996 | |
| 0.215 | 0.028 | 0.253 | Neurotensin receptor agonist | 0.253 0.02 CID_996 | CID_996 | |
| 0.191 | 0.005 | 0.191 | Acetylcholine release stimulant | 0.151 0.016 CID_996 | ||
| 0.235 | 0.05 | 0.248 | Non-steroidal antiinflammatory agent | 0.248 0.044 CID_996 | CID_996 | |
| 0.218 | 0.036 | 0.271 | Protein kinase stimulant | 0.271 0.022 CID_996 | CID_996 | |
| 0.201 | 0.018 | 0.222 | Cyclooxygenase 3 inhibitor | 0.222 0.013 CID_996 | CID_996 | |
| 0.272 | 0.091 | 0.414 | Streptokinase A inhibitor | 0.414 0.043 CID_996 | CID_996 | |
| 0.202 | 0.023 | 0.247 | Toll-Like receptor 2 antagonist | 0.247 0.01 CID_996 | CID_996 | |
| 0.228 | 0.049 | 0.247 | Insulin sensitizer | 0.247 0.036 CID_996 | CID_996 | |
| 0.187 | 0.009 | 0.207 | Heat shock protein 70 antagonist | 0.207 0.005 CID_996 | CID_996 | |
| 0.196 | 0.019 | 0.196 | Falcipain 3 inhibitor | 0.183 0.023 CID_996 | ||
| 0.19 | 0.013 | 0.214 | TRPA1 agonist | 0.214 0.008 CID_996 | CID_996 | |
| 0.219 | 0.043 | 0.219 | Tumour necrosis factor antagonist | 0.208 0.049 CID_996 | ||
| 0.187 | 0.011 | 0.187 | Sphingosine 1-phosphate receptor 2 antagonist | 0.184 0.013 CID_996 | ||
| 0.187 | 0.012 | 0.187 | Sphingosine 1-phosphate receptor 4 antagonist | 0.171 0.019 CID_996 | ||
| 0.203 | 0.029 | 0.203 | MAP kinase kinase 5 inhibitor | |||
| 0.177 | 0.004 | 0.177 | Granulocyte macrophage colony stimulating factor agonist | 0.174 0.004 CID_996 | ||
| 0.224 | 0.052 | 0.224 | Focal adhesion kinase 2 inhibitor | 0.161 0.114 CID_996 | ||
| 0.284 | 0.112 | 0.284 | Thioredoxin glutathione reductase inhibitor | 0.236 0.144 CID_996 | ||
| 0.209 | 0.038 | 0.348 | Melanin inhibitor | 0.348 0.016 CID_996 | CID_996 | |
| 0.184 | 0.013 | 0.184 | Sphingomyelinase inhibitor | 0.164 0.019 CID_996 | ||
| 0.175 | 0.005 | 0.175 | Glycine receptor agonist | 0.17 0.005 CID_996 | ||
| 0.187 | 0.017 | 0.215 | Mucolytic | 0.215 0.01 CID_996 | CID_996 | |
| 0.185 | 0.016 | 0.185 | Pregnane X receptor agonist | 0.176 0.021 CID_996 | ||
| 0.175 | 0.006 | 0.175 | Glutamate (mGluR7) agonist | 0.127 0.024 CID_996 | ||
| 0.183 | 0.015 | 0.283 | Carbonic anhydrase VI inhibitor | 0.283 0.007 CID_996 | CID_996 | |
| 0.173 | 0.006 | 0.173 | Lanosterol 14 alpha demethylase inhibitor | 0.165 0.008 CID_996 | ||
| 0.193 | 0.028 | 0.244 | Cholesterol synthesis inhibitor | 0.244 0.019 CID_996 | CID_996 | |
| 0.187 | 0.023 | 0.187 | Microtubule formation inhibitor | 0.182 0.025 CID_996 | ||
| 0.173 | 0.009 | 0.173 | Toll-Like receptor 3 antagonist | |||
| 0.198 | 0.036 | 0.21 | Death-associated protein kinase 2 inhibitor | 0.21 0.028 CID_996 | CID_996 | |
| 0.173 | 0.011 | 0.272 | Keratolytic | 0.272 0.004 CID_996 | CID_996 | |
| 0.17 | 0.009 | 0.17 | Histamine N-methyltransferase inhibitor | 0.163 0.01 CID_996 | ||
| 0.195 | 0.034 | 0.195 | Anesthetic local | 0.167 0.042 CID_996 | ||
| 0.255 | 0.094 | 0.296 | Immunostimulant | 0.296 0.079 CID_996 | CID_996 | |
| 0.169 | 0.01 | 0.169 | Aminopeptidase I inhibitor | 0.16 0.011 CID_996 | ||
| 0.174 | 0.017 | 0.174 | Calcium antagonist | 0.098 0.049 CID_996 | ||
| 0.17 | 0.016 | 0.259 | Alcohol dehydrogenase inhibitor | 0.259 0.007 CID_996 | CID_996 | |
| 0.159 | 0.006 | 0.159 | Glycine receptor antagonist | 0.137 0.011 CID_996 | ||
| 0.159 | 0.006 | 0.202 | GABA aminotransferase inhibitor | 0.202 0.004 CID_996 | CID_996 | |
| 0.174 | 0.022 | 0.19 | Interleukin 8 antagonist | 0.19 0.015 CID_996 | CID_996 | |
| 0.166 | 0.014 | 0.177 | Transcription factor STAT6 inhibitor | 0.177 0.011 CID_996 | CID_996 | |
| 0.158 | 0.006 | 0.173 | Purinergic P2X1 antagonist | 0.173 0.005 CID_996 | CID_996 | |
| 0.189 | 0.038 | 0.189 | Nav1.2 sodium channel blocker | 0.148 0.058 CID_996 | ||
| 0.181 | 0.03 | 0.215 | Adenylate cyclase inhibitor | 0.215 0.023 CID_996 | CID_996 | |
| 0.203 | 0.054 | 0.203 | Lipocortins synthesis antagonist | 0.166 0.085 CID_996 | ||
| 0.175 | 0.026 | 0.175 | Beta amyloid protein antagonist | 0.15 0.041 CID_996 | ||
| 0.161 | 0.013 | 0.171 | Anabolic | 0.171 0.009 CID_996 | CID_996 | |
| 0.189 | 0.041 | 0.189 | Toll-Like receptor 9 antagonist | 0.145 0.066 CID_996 | ||
| 0.174 | 0.027 | 0.218 | Expectorant | 0.218 0.017 CID_996 | CID_996 | |
| 0.173 | 0.025 | 0.173 | Nav1.1 sodium channel blocker | 0.146 0.034 CID_996 | ||
| 0.192 | 0.047 | 0.192 | Diuretic | 0.169 0.061 CID_996 | ||
| 0.167 | 0.023 | 0.18 | Protein kinase C gamma inhibitor | 0.18 0.019 CID_996 | CID_996 | |
| 0.204 | 0.061 | 0.204 | LIM domain kinase 1 inhibitor | 0.168 0.082 CID_996 | ||
| 0.158 | 0.015 | 0.158 | Thioredoxin inhibitor | 0.156 0.015 CID_996 | ||
| 0.22 | 0.077 | 0.22 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.164 | 0.021 | 0.164 | DNA repair enzyme inhibitor | 0.162 0.022 CID_996 | ||
| 0.187 | 0.044 | 0.187 | Thiol protease inhibitor | 0.155 0.064 CID_996 | ||
| 0.145 | 0.004 | 0.145 | Exportin-1 inhibitor | 0.104 0.008 CID_996 | ||
| 0.166 | 0.026 | 0.187 | Vanilloid 1 agonist | 0.187 0.016 CID_996 | CID_996 | |
| 0.149 | 0.009 | 0.176 | Carbonic anhydrase VB inhibitor | 0.176 0.006 CID_996 | CID_996 | |
| 0.145 | 0.006 | 0.198 | D-Ala-D-Ala ligase inhibitor | 0.198 0.003 CID_996 | CID_996 | |
| 0.186 | 0.049 | 0.186 | Acetylcholine M1 receptor antagonist | 0.183 0.05 CID_996 | ||
| 0.161 | 0.024 | 0.221 | Potassium channel (Ca-activated) activator | 0.221 0.011 CID_996 | CID_996 | |
| 0.169 | 0.033 | 0.169 | Antibacterial (Helicobacter pylori) | 0.163 0.037 CID_996 | ||
| 0.14 | 0.004 | 0.14 | Glutamate (mGluR7) antagonist | 0.135 0.004 CID_996 | ||
| 0.155 | 0.021 | 0.226 | Carbonic anhydrase XIII inhibitor | 0.226 0.011 CID_996 | CID_996 | |
| 0.139 | 0.005 | 0.192 | Estrogen-related receptor beta agonist | 0.192 0.003 CID_996 | CID_996 | |
| 0.19 | 0.056 | 0.261 | Heat shock protein 90 alpha antagonist | 0.261 0.023 CID_996 | CID_996 | |
| 0.139 | 0.004 | 0.139 | Glutamate (mGluR6) antagonist | 0.117 0.006 CID_996 | ||
| 0.144 | 0.01 | 0.144 | Sphingosine 1-phosphate receptor 4 agonist | 0.135 0.012 CID_996 | ||
| 0.17 | 0.037 | 0.17 | Nav1.3 sodium channel blocker | 0.125 0.069 CID_996 | ||
| 0.138 | 0.005 | 0.138 | Potassium channel intermediate-conductance Ca-activated blocker | 0.073 0.024 CID_996 | ||
| 0.147 | 0.015 | 0.17 | Carbonic anhydrase V inhibitor | 0.17 0.01 CID_996 | CID_996 | |
| 0.136 | 0.004 | 0.136 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.107 0.01 CID_996 | ||
| 0.189 | 0.057 | 0.189 | Antipruritic | 0.178 0.066 CID_996 | ||
| 0.169 | 0.038 | 0.181 | Alkylator | 0.181 0.032 CID_996 | CID_996 | |
| 0.255 | 0.124 | 0.294 | Prostaglandin dehydrogenase inhibitor | 0.294 0.105 CID_996 | CID_996 | |
| 0.148 | 0.017 | 0.148 | MAP kinase kinase 1 inhibitor | 0.139 0.021 CID_996 | ||
| 0.158 | 0.027 | 0.208 | Papain-like protease (SARS coronavirus) inhibitor | 0.208 0.009 CID_996 | CID_996 | |
| 0.249 | 0.119 | 0.351 | Interleukin 2 agonist | 0.351 0.045 CID_996 | CID_996 | |
| 0.136 | 0.006 | 0.136 | Acetylcholine M5 receptor agonist | 0.091 0.026 CID_996 | ||
| 0.134 | 0.004 | 0.134 | Phospholipase D inhibitor | 0.112 0.009 CID_996 | ||
| 0.134 | 0.005 | 0.174 | GABA B receptor agonist | 0.174 0.004 CID_996 | CID_996 | |
| 0.171 | 0.042 | 0.171 | MAP kinase 3 inhibitor | 0.145 0.076 CID_996 | ||
| 0.151 | 0.022 | 0.151 | Nitric-oxide synthase inhibitor | 0.106 0.051 CID_996 | ||
| 0.131 | 0.003 | 0.215 | Dopamine D5 agonist | 0.215 0.002 CID_996 | CID_996 | |
| 0.147 | 0.019 | 0.22 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.22 0.008 CID_996 | CID_996 | |
| 0.14 | 0.012 | 0.14 | Bromodomain-containing protein 2 inhibitor | 0.102 0.038 CID_996 | ||
| 0.18 | 0.052 | 0.18 | Cyclin-dependent kinase 8 inhibitor | 0.144 0.085 CID_996 | ||
| 0.205 | 0.079 | 0.205 | Anticonvulsant | |||
| 0.252 | 0.126 | 0.409 | Sodium/bile acid cotransporter inhibitor | 0.409 0.014 CID_996 | CID_996 | |
| 0.167 | 0.042 | 0.171 | Neuropeptide Y1 antagonist | 0.171 0.038 CID_996 | CID_996 | |
| 0.132 | 0.006 | 0.132 | 5 Hydroxytryptamine 3 agonist | 0.108 0.012 CID_996 | ||
| 0.128 | 0.003 | 0.128 | Glucose-6-phosphate isomerase inhibitor | 0.118 0.004 CID_996 | ||
| 0.134 | 0.01 | 0.134 | NMDA receptor agonist | 0.116 0.014 CID_996 | ||
| 0.138 | 0.014 | 0.162 | Myeloperoxidase inhibitor | 0.162 0.009 CID_996 | CID_996 | |
| 0.135 | 0.012 | 0.135 | mTOR complex 2 inhibitor | 0.123 0.016 CID_996 | ||
| 0.129 | 0.006 | 0.143 | CC chemokine 5 receptor agonist | 0.143 0.004 CID_996 | CID_996 | |
| 0.128 | 0.005 | 0.128 | Vanilloid 4 agonist | 0.105 0.013 CID_996 | ||
| 0.171 | 0.048 | 0.171 | Hemostatic | 0.168 0.05 CID_996 | ||
| 0.134 | 0.012 | 0.134 | Nicotinic alpha4beta2 receptor antagonist | 0.098 0.032 CID_996 | ||
| 0.126 | 0.004 | 0.126 | Fumarate hydratase inhibitor | 0.093 0.006 CID_996 | ||
| 0.139 | 0.019 | 0.139 | Inducible nitric-oxide synthase inhibitor | 0.104 0.034 CID_996 | ||
| 0.169 | 0.048 | 0.214 | Alkaline phosphatase inhibitor | 0.214 0.028 CID_996 | CID_996 | |
| 0.233 | 0.112 | 0.359 | Lipoxygenase inhibitor | 0.359 0.048 CID_996 | CID_996 | |
| 0.208 | 0.089 | 0.291 | Peptidyltransferase inhibitor | 0.291 0.028 CID_996 | CID_996 | |
| 0.134 | 0.014 | 0.152 | Carbonic anhydrase VA inhibitor | 0.152 0.01 CID_996 | CID_996 | |
| 0.154 | 0.034 | 0.154 | Death-associated protein kinase 1 inhibitor | |||
| 0.145 | 0.026 | 0.163 | Urease inhibitor | 0.163 0.018 CID_996 | CID_996 | |
| 0.122 | 0.003 | 0.122 | Glutamate (mGluR1a) agonist | 0.08 0.004 CID_996 | ||
| 0.126 | 0.007 | 0.126 | NMDA receptor glycine site agonist | 0.109 0.013 CID_996 | ||
| 0.128 | 0.012 | 0.128 | Ornithine carbamoyltransferase inhibitor | 0.096 0.017 CID_996 | ||
| 0.151 | 0.035 | 0.151 | GABA receptor agonist | 0.121 0.056 CID_996 | ||
| 0.146 | 0.029 | 0.146 | Nav1.5 sodium channel blocker | 0.115 0.061 CID_996 | ||
| 0.145 | 0.029 | 0.145 | Gastric antisecretory | 0.122 0.041 CID_996 | ||
| 0.161 | 0.047 | 0.161 | Sodium channel (voltage-gated) blocker | |||
| 0.145 | 0.031 | 0.148 | Caspase 3 inhibitor | 0.148 0.029 CID_996 | CID_996 | |
| 0.133 | 0.02 | 0.264 | Macrophage migration inhibitory factor inhibitor | 0.264 0.005 CID_996 | CID_996 | |
| 0.136 | 0.024 | 0.139 | Interleukin 1 beta converting enzyme inhibitor | 0.139 0.022 CID_996 | CID_996 | |
| 0.141 | 0.029 | 0.208 | Beta glucuronidase inhibitor | 0.208 0.012 CID_996 | CID_996 | |
| 0.114 | 0.003 | 0.114 | Alpha 1d adrenoreceptor agonist | 0.101 0.004 CID_996 | ||
| 0.168 | 0.057 | 0.249 | Heat shock protein 90 antagonist | 0.249 0.021 CID_996 | CID_996 | |
| 0.129 | 0.018 | 0.135 | Phosphodiesterase 6D inhibitor | 0.135 0.015 CID_996 | CID_996 | |
| 0.117 | 0.008 | 0.213 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.213 0.004 CID_996 | CID_996 | |
| 0.123 | 0.014 | 0.123 | Caspase 7 inhibitor | 0.102 0.026 CID_996 | ||
| 0.129 | 0.02 | 0.133 | Ornithine decarboxylase inhibitor | 0.133 0.018 CID_996 | CID_996 | |
| 0.14 | 0.032 | 0.14 | Sphingosine 1-phosphate receptor 2 agonist | 0.111 0.072 CID_996 | ||
| 0.127 | 0.019 | 0.132 | Glutathione S-transferase inhibitor | 0.132 0.017 CID_996 | CID_996 | |
| 0.294 | 0.187 | 0.294 | MAP kinase 1 inhibitor | 0.245 0.239 CID_996 | ||
| 0.147 | 0.04 | 0.147 | Alpha 2b adrenoreceptor antagonist | 0.125 0.054 CID_996 | ||
| 0.122 | 0.016 | 0.122 | Interferon agonist | 0.106 0.024 CID_996 | ||
| 0.109 | 0.004 | 0.109 | Adenylate cyclase 1 inhibitor | 0.104 0.004 CID_996 | ||
| 0.19 | 0.084 | 0.19 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.111 | 0.006 | 0.133 | MAP kinase kinase 7 inhibitor | 0.133 0.003 CID_996 | CID_996 | |
| 0.156 | 0.052 | 0.156 | MAP3K9 inhibitor | 0.144 0.07 CID_996 | ||
| 0.15 | 0.046 | 0.15 | Proteasome inhibitor | 0.145 0.049 CID_996 | ||
| 0.147 | 0.043 | 0.147 | Interleukin 1b antagonist | |||
| 0.153 | 0.05 | 0.163 | MAP kinase kinase inhibitor | 0.163 0.044 CID_996 | CID_996 | |
| 0.177 | 0.075 | 0.249 | Amyloid beta precursor protein antagonist | 0.249 0.033 CID_996 | CID_996 | |
| 0.164 | 0.063 | 0.198 | Phospholipase A2 inhibitor | 0.198 0.043 CID_996 | CID_996 | |
| 0.137 | 0.036 | 0.162 | AMP-activated protein kinase stimulant | 0.162 0.021 CID_996 | CID_996 | |
| 0.107 | 0.006 | 0.107 | Nicotinic alpha3beta2 receptor antagonist | 0.071 0.017 CID_996 | ||
| 0.108 | 0.009 | 0.108 | Glutamate (mGluR group III) agonist | 0.075 0.014 CID_996 | ||
| 0.104 | 0.005 | 0.104 | Calcium channel P-type blocker | 0.085 0.011 CID_996 | ||
| 0.147 | 0.048 | 0.289 | Monophenol monooxygenase inhibitor | 0.289 0.019 CID_996 | CID_996 | |
| 0.153 | 0.054 | 0.153 | Toll-Like receptor antagonist | 0.136 0.066 CID_996 | ||
| 0.104 | 0.006 | 0.104 | Alpha-mannosidase inhibitor | 0.099 0.006 CID_996 | ||
| 0.116 | 0.018 | 0.116 | Thioredoxin reductase inhibitor | 0.108 0.023 CID_996 | ||
| 0.102 | 0.005 | 0.107 | Dihydroorotate oxidase inhibitor | 0.107 0.004 CID_996 | CID_996 | |
| 0.124 | 0.026 | 0.124 | Cathepsin G inhibitor | 0.124 0.026 CID_996 | ||
| 0.198 | 0.101 | 0.275 | Antiamyloidogenic | 0.275 0.06 CID_996 | CID_996 | |
| 0.126 | 0.029 | 0.166 | Protein kinase C zeta inhibitor | 0.166 0.017 CID_996 | CID_996 | |
| 0.102 | 0.006 | 0.102 | Corticotropin releasing factor 2 receptor antagonist | 0.069 0.03 CID_996 | ||
| 0.103 | 0.008 | 0.103 | Potassium channel (Tandem pore domain) blocker | 0.079 0.037 CID_996 | ||
| 0.135 | 0.04 | 0.216 | Xanthine oxidase inhibitor | 0.216 0.017 CID_996 | CID_996 | |
| 0.269 | 0.174 | 0.269 | Transcription factor inhibitor | 0.258 0.181 CID_996 | ||
| 0.27 | 0.176 | 0.403 | Alpha-glucosidase inhibitor | 0.403 0.113 CID_996 | CID_996 | |
| 0.107 | 0.013 | 0.107 | Alpha 2 adrenoreceptor agonist | 0.09 0.018 CID_996 | ||
| 0.101 | 0.007 | 0.11 | Sphingosine kinase 2 inhibitor | 0.11 0.005 CID_996 | CID_996 | |
| 0.117 | 0.023 | 0.131 | Bile acid receptor antagonist | 0.131 0.013 CID_996 | CID_996 | |
| 0.124 | 0.031 | 0.154 | Androgen antagonist | 0.154 0.021 CID_996 | CID_996 | |
| 0.113 | 0.021 | 0.115 | Na+ K+ transporting ATPase inhibitor | 0.115 0.019 CID_996 | CID_996 | |
| 0.099 | 0.007 | 0.099 | MDM2 inhibitor | 0.083 0.017 CID_996 | ||
| 0.155 | 0.063 | 0.155 | Activin receptor-like kinase 2 inhibitor | 0.124 0.091 CID_996 | ||
| 0.097 | 0.005 | 0.102 | Squalene epoxidase inhibitor | 0.102 0.005 CID_996 | CID_996 | |
| 0.097 | 0.006 | 0.097 | Mannosidase inhibitor | 0.094 0.006 CID_996 | ||
| 0.096 | 0.005 | 0.106 | Ryanodine receptor antagonist | 0.106 0.004 CID_996 | CID_996 | |
| 0.096 | 0.006 | 0.096 | Glutamate (mGluR4) antagonist | 0.067 0.011 CID_996 | ||
| 0.155 | 0.064 | 0.155 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.15 0.071 CID_996 | ||
| 0.104 | 0.014 | 0.104 | Protease 3C (Human rhinovirus) inhibitor | 0.087 0.022 CID_996 | ||
| 0.151 | 0.061 | 0.151 | Cytokine production inhibitor | 0.123 0.087 CID_996 | ||
| 0.099 | 0.009 | 0.136 | Topoisomerase II beta inhibitor | 0.136 0.005 CID_996 | CID_996 | |
| 0.121 | 0.031 | 0.121 | Potassium channel activator | 0.102 0.046 CID_996 | ||
| 0.107 | 0.017 | 0.107 | Carbonic anhydrase stimulant | 0.081 0.025 CID_996 | ||
| 0.101 | 0.012 | 0.101 | Interferon inducer | 0.087 0.019 CID_996 | ||
| 0.093 | 0.004 | 0.113 | Dopamine beta hydroxylase inhibitor | 0.113 0.004 CID_996 | CID_996 | |
| 0.101 | 0.013 | 0.104 | Protein kinase C beta inhibitor | 0.104 0.012 CID_996 | CID_996 | |
| 0.101 | 0.013 | 0.101 | Aryl hydrocarbon receptor antagonist | 0.093 0.017 CID_996 | ||
| 0.101 | 0.014 | 0.101 | 5 Hydroxytryptamine 2A agonist | 0.096 0.016 CID_996 | ||
| 0.091 | 0.004 | 0.091 | Pregnane X receptor antagonist | 0.087 0.005 CID_996 | ||
| 0.13 | 0.043 | 0.13 | Alpha 2c adrenoreceptor antagonist | 0.113 0.055 CID_996 | ||
| 0.103 | 0.016 | 0.103 | Secretase beta inhibitor | 0.082 0.034 CID_996 | ||
| 0.119 | 0.033 | 0.119 | Potassium channel (Voltage-sensitive) activator | |||
| 0.088 | 0.003 | 0.102 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.102 0.003 CID_996 | CID_996 | |
| 0.114 | 0.029 | 0.114 | Acetylcholine nicotinic agonist | 0.075 0.064 CID_996 | ||
| 0.107 | 0.022 | 0.107 | Benzodiazepine agonist | |||
| 0.093 | 0.009 | 0.095 | Transcription factor RelA inhibitor | 0.095 0.008 CID_996 | CID_996 | |
| 0.089 | 0.005 | 0.089 | Potassium channel (Inward rectifier) activator | 0.063 0.017 CID_996 | ||
| 0.088 | 0.005 | 0.088 | Immunoglobulin Fc receptor antagonist | 0.08 0.006 CID_996 | ||
| 0.089 | 0.006 | 0.089 | Glutamate (mGluR group III) antagonist | 0.068 0.01 CID_996 | ||
| 0.11 | 0.027 | 0.11 | Histamine H2 receptor antagonist | 0.084 0.056 CID_996 | ||
| 0.093 | 0.01 | 0.093 | Glucosylceramidase inhibitor | 0.088 0.012 CID_996 | ||
| 0.088 | 0.005 | 0.088 | Histamine H2 receptor agonist | 0.048 0.024 CID_996 | ||
| 0.092 | 0.009 | 0.092 | Aldosterone antagonist | 0.051 0.028 CID_996 | ||
| 0.098 | 0.015 | 0.111 | Androgen agonist | 0.111 0.011 CID_996 | CID_996 | |
| 0.132 | 0.05 | 0.132 | Calcium channel N-type blocker | |||
| 0.144 | 0.062 | 0.144 | Sodium channel blocker | |||
| 0.087 | 0.004 | 0.087 | GABA uptake inhibitor | 0.075 0.006 CID_996 | ||
| 0.085 | 0.004 | 0.085 | Glutamate (mGluR8) agonist | 0.076 0.004 CID_996 | ||
| 0.098 | 0.016 | 0.122 | NMDA 2C receptor antagonist | 0.122 0.01 CID_996 | CID_996 | |
| 0.119 | 0.037 | 0.119 | Acetylcholine agonist | |||
| 0.086 | 0.005 | 0.086 | Potassium channel (ATP-sensitive) activator | 0.059 0.016 CID_996 | ||
| 0.092 | 0.012 | 0.092 | Potassium channel (Ca-activated) blocker | |||
| 0.142 | 0.064 | 0.142 | Interleukin 1 antagonist | 0.113 0.099 CID_996 | ||
| 0.142 | 0.064 | 0.201 | MAO inhibitor | 0.201 0.04 CID_996 | CID_996 | |
| 0.097 | 0.018 | 0.097 | TRPA1 antagonist | 0.079 0.026 CID_996 | ||
| 0.09 | 0.012 | 0.09 | Cyclin D1 inhibitor | 0.087 0.013 CID_996 | ||
| 0.111 | 0.033 | 0.111 | Acetylcholine nicotinic antagonist | 0.082 0.052 CID_996 | ||
| 0.087 | 0.01 | 0.087 | Epithelial sodium channel blocker | 0.078 0.013 CID_996 | ||
| 0.082 | 0.005 | 0.082 | Potassium channel small-conductance Ca-activated activator | |||
| 0.095 | 0.018 | 0.095 | Potassium channel (ATP-sensitive) blocker | 0.091 0.02 CID_996 | ||
| 0.084 | 0.008 | 0.084 | Lysophosphatidic acid 3 receptor antagonist | 0.073 0.013 CID_996 | ||
| 0.132 | 0.056 | 0.133 | Acetylcholine muscarinic antagonist | 0.133 0.056 CID_996 | CID_996 | |
| 0.081 | 0.005 | 0.081 | Geranyltranstransferase inhibitor | 0.074 0.006 CID_996 | ||
| 0.157 | 0.082 | 0.17 | Cyclin-dependent kinase 3 inhibitor | 0.17 0.06 CID_996 | CID_996 | |
| 0.108 | 0.032 | 0.108 | Glutamate receptor agonist | |||
| 0.086 | 0.011 | 0.086 | Glutamate (mGluR group I) agonist | |||
| 0.079 | 0.004 | 0.079 | Kainate receptor agonist | 0.071 0.004 CID_996 | ||
| 0.136 | 0.061 | 0.136 | Glutamate receptor antagonist | 0.129 0.066 CID_996 | ||
| 0.089 | 0.015 | 0.13 | Heat shock protein 90 beta antagonist | 0.13 0.005 CID_996 | CID_996 | |
| 0.084 | 0.01 | 0.084 | Glutamate (mGluR5) agonist | 0.041 0.04 CID_996 | ||
| 0.121 | 0.047 | 0.148 | Mediator release inhibitor | 0.148 0.03 CID_996 | CID_996 | |
| 0.109 | 0.035 | 0.109 | Phosphodiesterase I inhibitor | 0.099 0.046 CID_996 | ||
| 0.079 | 0.005 | 0.079 | Cytokine production stimulant | 0.059 0.014 CID_996 | ||
| 0.082 | 0.008 | 0.082 | Glutamate (mGluR1a) antagonist | |||
| 0.079 | 0.005 | 0.079 | Glutamate (mGluR3) antagonist | 0.071 0.006 CID_996 | ||
| 0.078 | 0.004 | 0.078 | Nerve growth factor antagonist | 0.062 0.009 CID_996 | ||
| 0.101 | 0.027 | 0.101 | Alpha adrenoreceptor agonist | 0.092 0.031 CID_996 | ||
| 0.145 | 0.072 | 0.211 | MAP kinase kinase 4 inhibitor | 0.211 0.01 CID_996 | CID_996 | |
| 0.106 | 0.033 | 0.106 | GABA A receptor agonist | 0.082 0.061 CID_996 | ||
| 0.1 | 0.028 | 0.1 | Acetylcholine M4 receptor antagonist | |||
| 0.085 | 0.013 | 0.092 | Sphingosine kinase inhibitor | 0.092 0.01 CID_996 | CID_996 | |
| 0.085 | 0.014 | 0.085 | Sphingosine 1-phosphate receptor 3 antagonist | 0.085 0.014 CID_996 | ||
| 0.075 | 0.004 | 0.075 | Guanylate cyclase inhibitor | 0.072 0.004 CID_996 | ||
| 0.086 | 0.015 | 0.086 | Phosphodiesterase 1C inhibitor | 0.077 0.022 CID_996 | ||
| 0.075 | 0.004 | 0.075 | Histamine H1 receptor agonist | 0.048 0.022 CID_996 | ||
| 0.092 | 0.021 | 0.092 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.076 | 0.005 | 0.076 | Diamine oxidase inhibitor | 0.049 0.015 CID_996 | ||
| 0.09 | 0.02 | 0.148 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.148 0.007 CID_996 | CID_996 | |
| 0.121 | 0.052 | 0.189 | MAO A inhibitor | 0.189 0.031 CID_996 | CID_996 | |
| 0.089 | 0.02 | 0.089 | Glutamate (mGluR1) antagonist | |||
| 0.075 | 0.005 | 0.075 | Potassium channel Kv1.1 blocker | 0.046 0.016 CID_996 | ||
| 0.097 | 0.028 | 0.097 | Adenosine A3 receptor antagonist | 0.086 0.036 CID_996 | ||
| 0.081 | 0.012 | 0.081 | 5 Hydroxytryptamine 7 agonist | 0.075 0.015 CID_996 | ||
| 0.109 | 0.041 | 0.179 | Interleukin 12 antagonist | 0.179 0.007 CID_996 | CID_996 | |
| 0.089 | 0.022 | 0.089 | Orexin receptor 1 antagonist | |||
| 0.08 | 0.013 | 0.08 | Potassium channel (Inward rectifier) blocker | 0.05 0.035 CID_996 | ||
| 0.157 | 0.09 | 0.243 | Catenin beta inhibitor | 0.243 0.013 CID_996 | CID_996 | |
| 0.106 | 0.039 | 0.106 | Polo-like kinase-1 inhibitor | 0.083 0.075 CID_996 | ||
| 0.087 | 0.02 | 0.087 | Acetylcholine muscarinic agonist | |||
| 0.076 | 0.009 | 0.076 | Fructose-1,6-bisphosphatase inhibitor | 0.066 0.014 CID_996 | ||
| 0.082 | 0.015 | 0.082 | Phosphodiesterase 1A inhibitor | 0.061 0.04 CID_996 | ||
| 0.078 | 0.012 | 0.08 | Potassium channel Kv1.3 blocker | 0.08 0.012 CID_996 | CID_996 | |
| 0.073 | 0.008 | 0.086 | Dihydropteroate synthase inhibitor | 0.086 0.005 CID_996 | CID_996 | |
| 0.093 | 0.027 | 0.093 | Neuronal nicotinic receptor antagonist | 0.072 0.043 CID_996 | ||
| 0.073 | 0.008 | 0.073 | GABA B receptor antagonist | 0.063 0.011 CID_996 | ||
| 0.084 | 0.019 | 0.084 | Cyclin-dependent kinase 6 inhibitor | 0.06 0.041 CID_996 | ||
| 0.07 | 0.004 | 0.07 | Uridine phosphorylase inhibitor | 0.066 0.005 CID_996 | ||
| 0.082 | 0.017 | 0.101 | Fatty acid synthase inhibitor | 0.101 0.011 CID_996 | CID_996 | |
| 0.073 | 0.008 | 0.082 | Purinergic P2X4 antagonist | 0.082 0.006 CID_996 | CID_996 | |
| 0.124 | 0.06 | 0.13 | Protein kinase (CK2) alpha inhibitor | 0.13 0.056 CID_996 | CID_996 | |
| 0.074 | 0.01 | 0.074 | Dihydroorotase inhibitor | 0.06 0.017 CID_996 | ||
| 0.07 | 0.006 | 0.07 | 5 Hydroxytryptamine 2B agonist | 0.045 0.018 CID_996 | ||
| 0.15 | 0.087 | 0.26 | Growth hormone agonist | 0.26 0.041 CID_996 | CID_996 | |
| 0.1 | 0.037 | 0.16 | Adrenaline agonist | 0.16 0.012 CID_996 | CID_996 | |
| 0.092 | 0.029 | 0.092 | Amidase inhibitor | 0.088 0.032 CID_996 | ||
| 0.068 | 0.004 | 0.068 | Heme oxygenase inhibitor | 0.057 0.008 CID_996 | ||
| 0.072 | 0.009 | 0.072 | Cholesterol esterase inhibitor | 0.063 0.015 CID_996 | ||
| 0.084 | 0.021 | 0.124 | Beta 3 adrenoreceptor antagonist | 0.124 0.009 CID_996 | CID_996 | |
| 0.072 | 0.009 | 0.072 | CC chemokine 4 receptor antagonist | 0.047 0.033 CID_996 | ||
| 0.129 | 0.066 | 0.129 | Cholinergic antagonist | 0.121 0.073 CID_996 | ||
| 0.081 | 0.019 | 0.108 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.108 0.008 CID_996 | CID_996 | |
| 0.091 | 0.029 | 0.091 | Calcium channel L-type blocker | |||
| 0.153 | 0.091 | 0.315 | Dual specificity phosphatase inhibitor | 0.315 0.026 CID_996 | CID_996 | |
| 0.07 | 0.009 | 0.07 | Retinoid X alpha receptor agonist | 0.053 0.013 CID_996 | ||
| 0.143 | 0.082 | 0.143 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.065 | 0.004 | 0.065 | Vanilloid 3 antagonist | 0.059 0.005 CID_996 | ||
| 0.074 | 0.013 | 0.074 | Prolyl endopeptidase inhibitor | 0.06 0.024 CID_996 | ||
| 0.252 | 0.191 | 0.271 | DNA polymerase beta inhibitor | 0.271 0.18 CID_996 | CID_996 | |
| 0.095 | 0.035 | 0.163 | NMDA 2 receptor antagonist | 0.163 0.014 CID_996 | CID_996 | |
| 0.079 | 0.019 | 0.079 | Histone deacetylase SIRT3 inhibitor | 0.07 0.028 CID_996 | ||
| 0.088 | 0.028 | 0.088 | Nav1.7 sodium channel blocker | |||
| 0.074 | 0.015 | 0.151 | NMDA receptor subunit 3B antagonist | 0.151 0.006 CID_996 | CID_996 | |
| 0.13 | 0.071 | 0.228 | Cyclooxygenase 1 inhibitor | 0.228 0.026 CID_996 | CID_996 | |
| 0.113 | 0.053 | 0.12 | Protein kinase (CK2) inhibitor | 0.12 0.048 CID_996 | CID_996 | |
| 0.068 | 0.01 | 0.07 | Phosphoglycerate kinase inhibitor | 0.07 0.009 CID_996 | CID_996 | |
| 0.088 | 0.03 | 0.088 | Phosphodiesterase VI inhibitor | 0.086 0.033 CID_996 | ||
| 0.153 | 0.094 | 0.314 | Dual specificity phosphatase 3 inhibitor | 0.314 0.026 CID_996 | CID_996 | |
| 0.125 | 0.066 | 0.125 | Acetylcholine antagonist | 0.117 0.073 CID_996 | ||
| 0.103 | 0.045 | 0.172 | NMDA receptor antagonist | 0.172 0.019 CID_996 | CID_996 | |
| 0.092 | 0.034 | 0.172 | Estrogen receptor alpha antagonist | 0.172 0.01 CID_996 | CID_996 | |
| 0.071 | 0.013 | 0.071 | Adenosine deaminase inhibitor | 0.068 0.014 CID_996 | ||
| 0.075 | 0.017 | 0.075 | Acetylcholine M1 receptor agonist | |||
| 0.077 | 0.019 | 0.079 | Botulinum neurotoxin type A inhibitor | 0.079 0.017 CID_996 | CID_996 | |
| 0.075 | 0.017 | 0.075 | 5 Hydroxytryptamine 2 agonist | 0.052 0.036 CID_996 | ||
| 0.112 | 0.054 | 0.155 | MAO B inhibitor | 0.155 0.036 CID_996 | CID_996 | |
| 0.067 | 0.009 | 0.087 | Nicotinic acid receptor agonist | 0.087 0.005 CID_996 | CID_996 | |
| 0.081 | 0.024 | 0.081 | Acetylcholine M5 receptor antagonist | 0.068 0.032 CID_996 | ||
| 0.065 | 0.008 | 0.065 | Vascular adhesion protein 1 inhibitor | |||
| 0.112 | 0.056 | 0.112 | MAP kinase kinase kinase inhibitor | |||
| 0.066 | 0.01 | 0.066 | Kainate receptor 2 antagonist | 0.041 0.021 CID_996 | ||
| 0.067 | 0.011 | 0.067 | AICAR transformylase inhibitor | 0.064 0.012 CID_996 | ||
| 0.21 | 0.154 | 0.217 | Thyroid hormone antagonist | 0.217 0.147 CID_996 | CID_996 | |
| 0.075 | 0.019 | 0.075 | Nicotinic receptor alpha7 subunit antagonist | 0.054 0.036 CID_996 | ||
| 0.059 | 0.004 | 0.059 | Alpha 2a adrenoreceptor agonist | 0.047 0.004 CID_996 | ||
| 0.072 | 0.016 | 0.072 | Lysine-specific demethylase 1A inhibitor | 0.067 0.02 CID_996 | ||
| 0.131 | 0.076 | 0.131 | Calcium channel blocker | |||
| 0.081 | 0.026 | 0.081 | Orexin receptor antagonist | |||
| 0.062 | 0.006 | 0.062 | Lysophosphatidic acid 2 receptor antagonist | 0.045 0.01 CID_996 | ||
| 0.062 | 0.006 | 0.062 | Delayed rectifier potassium channel blocker | 0.052 0.01 CID_996 | ||
| 0.088 | 0.033 | 0.088 | Sphingosine 1-phosphate receptor antagonist | 0.088 0.033 CID_996 | ||
| 0.067 | 0.011 | 0.067 | Thymidine kinase inhibitor | 0.056 0.015 CID_996 | ||
| 0.07 | 0.015 | 0.099 | CD45 antagonist | 0.099 0.009 CID_996 | CID_996 | |
| 0.072 | 0.018 | 0.072 | Histamine agonist | |||
| 0.059 | 0.004 | 0.059 | Nicotinic alpha3beta4 receptor agonist | 0.043 0.008 CID_996 | ||
| 0.066 | 0.012 | 0.066 | Retinoid X receptor agonist | 0.055 0.016 CID_996 | ||
| 0.101 | 0.047 | 0.101 | Alpha 2d adrenoreceptor antagonist | |||
| 0.063 | 0.009 | 0.063 | Membrane dipeptidase inhibitor | 0.047 0.018 CID_996 | ||
| 0.247 | 0.193 | 0.273 | DNA directed DNA polymerase inhibitor | 0.273 0.177 CID_996 | CID_996 | |
| 0.1 | 0.046 | 0.1 | Pim-3 kinase inhibitor | 0.082 0.072 CID_996 | ||
| 0.058 | 0.004 | 0.058 | Glutamate (mGluR1) agonist | 0.04 0.005 CID_996 | ||
| 0.076 | 0.022 | 0.109 | NMDA 2A receptor antagonist | 0.109 0.011 CID_996 | CID_996 | |
| 0.259 | 0.205 | 0.528 | Apoptosis agonist | 0.528 0.066 CID_996 | CID_996 | |
| 0.068 | 0.014 | 0.068 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.105 | 0.051 | 0.105 | Phosphodiesterase 7B inhibitor | |||
| 0.078 | 0.024 | 0.078 | Phosphodiesterase 1B inhibitor | 0.065 0.035 CID_996 | ||
| 0.063 | 0.01 | 0.063 | Benzodiazepine antagonist | 0.046 0.037 CID_996 | ||
| 0.066 | 0.013 | 0.066 | Thymidylate synthase inhibitor | 0.061 0.017 CID_996 | ||
| 0.074 | 0.021 | 0.082 | Heme oxygenase stimulant | 0.082 0.014 CID_996 | CID_996 | |
| 0.061 | 0.009 | 0.061 | Acetylcholine M4 receptor agonist | |||
| 0.07 | 0.017 | 0.07 | DNA helicase inhibitor | 0.066 0.021 CID_996 | ||
| 0.058 | 0.006 | 0.058 | Free fatty acid receptor 1 antagonist | 0.05 0.009 CID_996 | ||
| 0.08 | 0.028 | 0.108 | Aromatase inhibitor | 0.108 0.02 CID_996 | CID_996 | |
| 0.072 | 0.019 | 0.1 | Carbonic anhydrase XIV inhibitor | 0.1 0.011 CID_996 | CID_996 | |
| 0.068 | 0.016 | 0.072 | Leukotriene C antagonist | 0.072 0.012 CID_996 | CID_996 | |
| 0.066 | 0.015 | 0.066 | Heparanase inhibitor | 0.065 0.016 CID_996 | ||
| 0.116 | 0.064 | 0.116 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.1 | 0.048 | 0.1 | Alpha 2 adrenoreceptor antagonist | 0.084 0.062 CID_996 | ||
| 0.056 | 0.005 | 0.059 | Protein kinase (CK2) beta inhibitor | 0.059 0.005 CID_996 | CID_996 | |
| 0.135 | 0.083 | 0.168 | Cyclooxygenase inhibitor | 0.168 0.058 CID_996 | CID_996 | |
| 0.087 | 0.035 | 0.087 | Epoxide hydrolase inhibitor | |||
| 0.058 | 0.007 | 0.058 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.04 0.012 CID_996 | ||
| 0.077 | 0.026 | 0.077 | 5 Hydroxytryptamine 5A antagonist | 0.064 0.039 CID_996 | ||
| 0.214 | 0.163 | 0.378 | Apoptosis antagonist | 0.378 0.045 CID_996 | CID_996 | |
| 0.068 | 0.017 | 0.068 | Oleamide hydrolase inhibitor | 0.051 0.027 CID_996 | ||
| 0.066 | 0.015 | 0.119 | NMDA receptor subunit 3A antagonist | 0.119 0.007 CID_996 | CID_996 | |
| 0.054 | 0.004 | 0.054 | Imidazoline I1 receptor antagonist | 0.025 0.01 CID_996 | ||
| 0.059 | 0.009 | 0.059 | Glutamate (mGluR4) agonist | 0.045 0.013 CID_996 | ||
| 0.154 | 0.105 | 0.529 | Amyloid beta aggregation inhibitor | 0.529 0.012 CID_996 | CID_996 | |
| 0.079 | 0.029 | 0.079 | Cannabinoid CB1 receptor agonist | |||
| 0.059 | 0.01 | 0.059 | Sirtuin 2 inhibitor | 0.049 0.013 CID_996 | ||
| 0.059 | 0.01 | 0.059 | AMPA 4 receptor antagonist | 0.056 0.012 CID_996 | ||
| 0.073 | 0.024 | 0.09 | Beta 1 adrenoreceptor antagonist | 0.09 0.013 CID_996 | CID_996 | |
| 0.171 | 0.123 | 0.607 | Free radical scavenger | 0.607 0.008 CID_996 | CID_996 | |
| 0.063 | 0.014 | 0.068 | Oxytocin agonist | 0.068 0.011 CID_996 | CID_996 | |
| 0.053 | 0.005 | 0.053 | Methionyl aminopeptidase 1 inhibitor | 0.039 0.013 CID_996 | ||
| 0.069 | 0.021 | 0.084 | Beta 2 adrenoreceptor agonist | 0.084 0.007 CID_996 | CID_996 | |
| 0.052 | 0.005 | 0.052 | Tryptophan 5 hydroxylase inhibitor | 0.042 0.012 CID_996 | ||
| 0.058 | 0.011 | 0.058 | Arginase inhibitor | 0.058 0.011 CID_996 | ||
| 0.075 | 0.028 | 0.122 | Xanthine dehydrogenase inhibitor | 0.122 0.011 CID_996 | CID_996 | |
| 0.077 | 0.03 | 0.107 | Beta adrenoreceptor antagonist | 0.107 0.014 CID_996 | CID_996 | |
| 0.051 | 0.004 | 0.051 | Nicotinic acid receptor 2 antagonist | 0.044 0.004 CID_996 | ||
| 0.055 | 0.009 | 0.055 | Retinoid X receptor antagonist | 0.049 0.013 CID_996 | ||
| 0.053 | 0.007 | 0.053 | Melatonin receptor 1A agonist | 0.036 0.018 CID_996 | ||
| 0.089 | 0.043 | 0.089 | Alpha 2a adrenoreceptor antagonist | 0.08 0.048 CID_996 | ||
| 0.056 | 0.01 | 0.056 | Angiotensin AT1 receptor antagonist | 0.044 0.026 CID_996 | ||
| 0.05 | 0.004 | 0.05 | Nicotinic alpha4beta2 receptor agonist | 0.035 0.012 CID_996 | ||
| 0.052 | 0.007 | 0.063 | CF transmembrane conductance regulator antagonist | 0.063 0.004 CID_996 | CID_996 | |
| 0.067 | 0.022 | 0.067 | AMPA receptor antagonist | 0.057 0.026 CID_996 | ||
| 0.049 | 0.004 | 0.049 | Purinergic P2Y15 antagonist | 0.043 0.005 CID_996 | ||
| 0.074 | 0.028 | 0.074 | Dopamine uptake inhibitor | 0.055 0.043 CID_996 | ||
| 0.055 | 0.009 | 0.055 | Integrin alpha2 antagonist | 0.041 0.02 CID_996 | ||
| 0.072 | 0.027 | 0.072 | Nicotinic neuronal receptor agonist | |||
| 0.053 | 0.009 | 0.053 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.056 | 0.011 | 0.056 | Sphingosine kinase 1 inhibitor | 0.056 0.012 CID_996 | ||
| 0.05 | 0.005 | 0.059 | Glutamate (mGluR3) agonist | 0.059 0.004 CID_996 | CID_996 | |
| 0.054 | 0.009 | 0.054 | MAP3K5 inhibitor | 0.042 0.021 CID_996 | ||
| 0.199 | 0.154 | 0.199 | Thyroid hormone beta antagonist | 0.199 0.154 CID_996 | ||
| 0.063 | 0.018 | 0.063 | Carbonic anhydrase IV inhibitor | 0.053 0.023 CID_996 | ||
| 0.062 | 0.017 | 0.062 | Alpha 1b adrenoreceptor agonist | |||
| 0.072 | 0.028 | 0.072 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.049 | 0.004 | 0.049 | Protease (Human cytomegalovirus) inhibitor | 0.022 0.015 CID_996 | ||
| 0.048 | 0.004 | 0.064 | Estrogen-related receptor gamma antagonist | 0.064 0.002 CID_996 | CID_996 | |
| 0.05 | 0.006 | 0.05 | Epoxide hydrolase 1 inhibitor | 0.028 0.027 CID_996 | ||
| 0.079 | 0.035 | 0.081 | Carbonic anhydrase inhibitor | 0.081 0.034 CID_996 | CID_996 | |
| 0.068 | 0.025 | 0.068 | Nicotinic alpha7 receptor agonist | |||
| 0.056 | 0.013 | 0.056 | Dihydrofolate reductase inhibitor | 0.045 0.028 CID_996 | ||
| 0.059 | 0.015 | 0.059 | Histone deacetylase 7 inhibitor | 0.034 0.029 CID_996 | ||
| 0.087 | 0.044 | 0.087 | T cell inhibitor | |||
| 0.104 | 0.061 | 0.333 | 5-Lipoxygenase inhibitor | 0.333 0.008 CID_996 | CID_996 | |
| 0.069 | 0.026 | 0.069 | 5 Hydroxytryptamine 5 antagonist | 0.057 0.041 CID_996 | ||
| 0.061 | 0.018 | 0.061 | Histamine H4 receptor antagonist | |||
| 0.074 | 0.032 | 0.074 | Cannabinoid CB1 receptor antagonist | |||
| 0.139 | 0.097 | 0.139 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.058 | 0.017 | 0.058 | Kainate receptor antagonist | 0.048 0.022 CID_996 | ||
| 0.057 | 0.015 | 0.064 | Urate transporter 1 inhibitor | 0.064 0.013 CID_996 | CID_996 | |
| 0.049 | 0.008 | 0.049 | Ceramide glucosyltransferase inhibitor | 0.048 0.009 CID_996 | ||
| 0.064 | 0.023 | 0.064 | Thromboxane synthase inhibitor | 0.06 0.027 CID_996 | ||
| 0.044 | 0.004 | 0.044 | Vanilloid 2 agonist | 0.043 0.004 CID_996 | ||
| 0.078 | 0.037 | 0.078 | CDC7 inhibitor | |||
| 0.048 | 0.007 | 0.048 | Methionyl aminopeptidase 2 inhibitor | 0.029 0.014 CID_996 | ||
| 0.069 | 0.028 | 0.069 | Alpha 1 adrenoreceptor agonist | 0.059 0.037 CID_996 | ||
| 0.062 | 0.022 | 0.062 | 5 Hydroxytryptamine 4 antagonist | 0.047 0.044 CID_996 | ||
| 0.123 | 0.082 | 0.123 | Glycogen synthase kinase-3 alpha inhibitor | 0.121 0.084 CID_996 | ||
| 0.061 | 0.02 | 0.061 | HCV NS3/NS4A protease inhibitor | 0.046 0.039 CID_996 | ||
| 0.044 | 0.003 | 0.044 | Complement factor 1s inhibitor | 0.033 0.005 CID_996 | ||
| 0.177 | 0.137 | 0.187 | MAP-kinase-activated kinase 5 inhibitor | 0.187 0.122 CID_996 | CID_996 | |
| 0.078 | 0.038 | 0.078 | Elastase 1 inhibitor | 0.066 0.052 CID_996 | ||
| 0.048 | 0.008 | 0.048 | Retinoid X alpha receptor antagonist | 0.041 0.014 CID_996 | ||
| 0.064 | 0.024 | 0.064 | Sphingosine 1-phosphate receptor 1 antagonist | 0.063 0.024 CID_996 | ||
| 0.11 | 0.07 | 0.11 | Calcium channel (voltage-sensitive) blocker | |||
| 0.071 | 0.032 | 0.071 | Carbonic anhydrase IX inhibitor | 0.068 0.033 CID_996 | ||
| 0.079 | 0.04 | 0.079 | Prostaglandin-E synthase inhibitor | 0.073 0.045 CID_996 | ||
| 0.043 | 0.004 | 0.043 | Hedgehog signaling activator | 0.041 0.004 CID_996 | ||
| 0.043 | 0.005 | 0.043 | Lysophosphatidic acid receptor 1 agonist | 0.03 0.011 CID_996 | ||
| 0.154 | 0.116 | 0.154 | Death-associated protein kinase 3 inhibitor | |||
| 0.065 | 0.027 | 0.065 | Toll-Like receptor 8 antagonist | |||
| 0.045 | 0.006 | 0.045 | Adenosine uptake inhibitor | 0.034 0.027 CID_996 | ||
| 0.061 | 0.023 | 0.061 | Bombesin 2 receptor antagonist | 0.058 0.026 CID_996 | ||
| 0.047 | 0.009 | 0.069 | ATP citrate lysase inhibitor | 0.069 0.004 CID_996 | CID_996 | |
| 0.071 | 0.033 | 0.071 | Adrenaline uptake inhibitor | |||
| 0.057 | 0.019 | 0.057 | Leukocyte elastase inhibitor | 0.04 0.034 CID_996 | ||
| 0.054 | 0.016 | 0.066 | Liver X receptor alpha agonist | 0.066 0.01 CID_996 | CID_996 | |
| 0.061 | 0.023 | 0.083 | Beta 2 adrenoreceptor antagonist | 0.083 0.011 CID_996 | CID_996 | |
| 0.041 | 0.004 | 0.041 | Acid ceramidase inhibitor | 0.027 0.013 CID_996 | ||
| 0.057 | 0.02 | 0.057 | Nicotinic receptor alpha3 subunit antagonist | 0.041 0.034 CID_996 | ||
| 0.052 | 0.015 | 0.052 | TRPM8 blocker | 0.036 0.03 CID_996 | ||
| 0.046 | 0.01 | 0.057 | Liver X receptor beta antagonist | 0.057 0.006 CID_996 | CID_996 | |
| 0.04 | 0.003 | 0.04 | Carbonic anhydrase VIII inhibitor | 0.021 0.008 CID_996 | ||
| 0.04 | 0.003 | 0.04 | Carbonic anhydrase X inhibitor | 0.021 0.008 CID_996 | ||
| 0.044 | 0.008 | 0.044 | Kynurenine 3 monooxygenase inhibitor | 0.03 0.015 CID_996 | ||
| 0.047 | 0.011 | 0.047 | Peptide deformylase inhibitor | 0.029 0.022 CID_996 | ||
| 0.069 | 0.033 | 0.069 | I kappa B kinase 2 inhibitor | 0.066 0.038 CID_996 | ||
| 0.057 | 0.021 | 0.078 | Carbonic anhydrase VII inhibitor | 0.078 0.013 CID_996 | CID_996 | |
| 0.042 | 0.006 | 0.042 | MAP3K8 inhibitor | |||
| 0.069 | 0.033 | 0.069 | Adenosine A1 receptor antagonist | 0.059 0.04 CID_996 | ||
| 0.091 | 0.055 | 0.091 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.067 | 0.031 | 0.067 | Carbonic anhydrase II inhibitor | 0.065 0.032 CID_996 | ||
| 0.076 | 0.04 | 0.076 | Peroxisome proliferator-activated receptor gamma antagonist | 0.076 0.041 CID_996 | ||
| 0.039 | 0.005 | 0.039 | Glucosylceramidase stimulant | |||
| 0.066 | 0.031 | 0.066 | Carbonic anhydrase I inhibitor | 0.061 0.035 CID_996 | ||
| 0.04 | 0.006 | 0.04 | Integrin alpha2beta1 antagonist | 0.029 0.014 CID_996 | ||
| 0.05 | 0.016 | 0.05 | Histone deacetylase 9 inhibitor | 0.04 0.026 CID_996 | ||
| 0.049 | 0.015 | 0.049 | Farnesoid X receptor agonist | 0.044 0.02 CID_996 | ||
| 0.044 | 0.01 | 0.044 | Angiotensin II receptor antagonist | 0.034 0.024 CID_996 | ||
| 0.046 | 0.013 | 0.087 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.087 0.005 CID_996 | CID_996 | |
| 0.04 | 0.007 | 0.04 | 5 Hydroxytryptamine 6 agonist | 0.027 0.023 CID_996 | ||
| 0.063 | 0.03 | 0.063 | GABA receptor antagonist | 0.054 0.038 CID_996 | ||
| 0.158 | 0.125 | 0.158 | Growth factor agonist | |||
| 0.116 | 0.084 | 0.116 | Cyclooxygenase 2 inhibitor | 0.116 0.084 CID_996 | ||
| 0.042 | 0.01 | 0.042 | Lysine carboxypeptidase inhibitor | 0.04 0.01 CID_996 | ||
| 0.077 | 0.044 | 0.077 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.038 | 0.005 | 0.038 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.032 0.009 CID_996 | ||
| 0.086 | 0.053 | 0.086 | I kappa B kinase inhibitor | 0.078 0.063 CID_996 | ||
| 0.139 | 0.107 | 0.193 | Interleukin 6 antagonist | 0.193 0.045 CID_996 | CID_996 | |
| 0.054 | 0.022 | 0.147 | Estradiol 17 beta-dehydrogenase inhibitor | 0.147 0.006 CID_996 | CID_996 | |
| 0.043 | 0.011 | 0.043 | Cholesterol ester transfer protein antagonist | 0.034 0.018 CID_996 | ||
| 0.087 | 0.055 | 0.087 | Bcr-Abl kinase inhibitor | 0.081 0.064 CID_996 | ||
| 0.056 | 0.024 | 0.056 | Sodium/calcium exchanger inhibitor | |||
| 0.036 | 0.004 | 0.036 | Cyclin T1 inhibitor | 0.021 0.01 CID_996 | ||
| 0.075 | 0.044 | 0.075 | Cannabinoid receptor antagonist | |||
| 0.071 | 0.039 | 0.113 | Dopamine D1 antagonist | 0.113 0.021 CID_996 | CID_996 | |
| 0.063 | 0.032 | 0.063 | Cyclin A1 inhibitor | |||
| 0.061 | 0.03 | 0.061 | MAP kinase kinase 9 inhibitor | |||
| 0.037 | 0.006 | 0.045 | Prostaglandin F2 alpha agonist | 0.045 0.005 CID_996 | CID_996 | |
| 0.038 | 0.007 | 0.038 | Thymidine phosphorylase inhibitor | 0.031 0.011 CID_996 | ||
| 0.097 | 0.066 | 0.097 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.047 | 0.016 | 0.047 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.066 | 0.035 | 0.066 | Collagenase 3 inhibitor | 0.053 0.052 CID_996 | ||
| 0.04 | 0.009 | 0.053 | Sodium/glucose cotransporter 2 inhibitor | 0.053 0.006 CID_996 | CID_996 | |
| 0.045 | 0.015 | 0.048 | Leukotriene C4 antagonist | 0.048 0.012 CID_996 | CID_996 | |
| 0.059 | 0.029 | 0.059 | Thromboxane A2 antagonist | 0.054 0.033 CID_996 | ||
| 0.124 | 0.094 | 0.145 | CC chemokine 6 receptor antagonist | 0.145 0.029 CID_996 | CID_996 | |
| 0.059 | 0.029 | 0.064 | Dihydroorotate dehydrogenase inhibitor | 0.064 0.025 CID_996 | CID_996 | |
| 0.054 | 0.023 | 0.054 | Purinergic P2Y antagonist | 0.047 0.029 CID_996 | ||
| 0.058 | 0.028 | 0.058 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.093 | 0.063 | 0.147 | Breast cancer-resistant protein inhibitor | 0.147 0.025 CID_996 | CID_996 | |
| 0.034 | 0.004 | 0.034 | Alpha 2b adrenoreceptor agonist | 0.024 0.006 CID_996 | ||
| 0.034 | 0.005 | 0.034 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.03 0.008 CID_996 | ||
| 0.061 | 0.032 | 0.061 | Thromboxane antagonist | 0.057 0.035 CID_996 | ||
| 0.033 | 0.004 | 0.033 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.027 0.005 CID_996 | ||
| 0.047 | 0.018 | 0.047 | Glutamate (mGluR group II) antagonist | 0.035 0.032 CID_996 | ||
| 0.06 | 0.031 | 0.06 | GABA A receptor antagonist | 0.05 0.041 CID_996 | ||
| 0.038 | 0.009 | 0.049 | CXC chemokine 2 receptor antagonist | 0.049 0.006 CID_996 | CID_996 | |
| 0.033 | 0.004 | 0.048 | Nicotinic acid receptor 1 antagonist | 0.048 0.003 CID_996 | CID_996 | |
| 0.04 | 0.011 | 0.04 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.031 0.016 CID_996 | ||
| 0.069 | 0.04 | 0.069 | Neutrophil collagenase inhibitor | 0.067 0.042 CID_996 | ||
| 0.036 | 0.008 | 0.036 | Myristoyl transferase inhibitor | |||
| 0.056 | 0.028 | 0.056 | Dopamine transporter inhibitor | |||
| 0.033 | 0.004 | 0.033 | Alpha 2c adrenoreceptor agonist | 0.019 0.012 CID_996 | ||
| 0.149 | 0.121 | 0.149 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.044 | 0.016 | 0.044 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.034 0.03 CID_996 | ||
| 0.064 | 0.036 | 0.079 | Acetylcholine M3 receptor antagonist | 0.079 0.026 CID_996 | CID_996 | |
| 0.041 | 0.013 | 0.041 | AMPA 3 receptor antagonist | 0.036 0.016 CID_996 | ||
| 0.041 | 0.013 | 0.041 | Dipeptidyl peptidase II inhibitor | |||
| 0.051 | 0.023 | 0.051 | Toll-Like receptor 2 agonist | 0.04 0.029 CID_996 | ||
| 0.062 | 0.035 | 0.077 | Ribonucleotide reductase inhibitor | 0.077 0.028 CID_996 | CID_996 | |
| 0.097 | 0.07 | 0.642 | Estrogen receptor beta antagonist | 0.642 0.003 CID_996 | CID_996 | |
| 0.061 | 0.034 | 0.075 | Ribonucleoside-diphosphate reductase inhibitor | 0.075 0.027 CID_996 | CID_996 | |
| 0.047 | 0.02 | 0.047 | 5-Alpha-reductase inhibitor | 0.044 0.021 CID_996 | ||
| 0.045 | 0.019 | 0.045 | Factor XIIIa inhibitor | |||
| 0.075 | 0.048 | 0.083 | Metalloproteinase-9 inhibitor | 0.083 0.042 CID_996 | CID_996 | |
| 0.055 | 0.028 | 0.06 | Phosphorylase inhibitor | 0.06 0.025 CID_996 | CID_996 | |
| 0.06 | 0.033 | 0.069 | Carbonic anhydrase XII inhibitor | 0.069 0.029 CID_996 | CID_996 | |
| 0.045 | 0.018 | 0.045 | Inosine monophosphate dehydrogenase inhibitor | 0.042 0.02 CID_996 | ||
| 0.051 | 0.024 | 0.051 | Sphingosine 1-phosphate receptor agonist | 0.043 0.033 CID_996 | ||
| 0.03 | 0.004 | 0.03 | Lysophosphatidic acid receptor 3 agonist | 0.017 0.007 CID_996 | ||
| 0.049 | 0.023 | 0.049 | Histone deacetylase 8 inhibitor | 0.038 0.032 CID_996 | ||
| 0.055 | 0.029 | 0.055 | Antimetabolite | 0.043 0.037 CID_996 | ||
| 0.066 | 0.04 | 0.066 | Adenosine A2a receptor antagonist | 0.055 0.05 CID_996 | ||
| 0.031 | 0.005 | 0.031 | Isoleucine-tRNA ligase inhibitor | 0.029 0.006 CID_996 | ||
| 0.093 | 0.067 | 0.093 | Butyrylcholinesterase inhibitor | |||
| 0.043 | 0.018 | 0.043 | Orexin receptor 2 antagonist | |||
| 0.048 | 0.022 | 0.048 | Sphingosine 1-phosphate receptor 1 agonist | 0.042 0.029 CID_996 | ||
| 0.029 | 0.003 | 0.029 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.022 0.004 CID_996 | ||
| 0.068 | 0.042 | 0.068 | Histone deacetylase inhibitor | |||
| 0.112 | 0.086 | 0.142 | M17 leucyl aminopeptidase inhibitor | 0.142 0.061 CID_996 | CID_996 | |
| 0.057 | 0.032 | 0.057 | Cannabinoid CB2 receptor antagonist | |||
| 0.04 | 0.015 | 0.044 | Liver X receptor beta agonist | 0.044 0.013 CID_996 | CID_996 | |
| 0.048 | 0.022 | 0.049 | CDK5/p25 inhibitor | 0.049 0.022 CID_996 | CID_996 | |
| 0.03 | 0.004 | 0.034 | NMDA receptor phencyclidine site antagonist | 0.034 0.004 CID_996 | CID_996 | |
| 0.045 | 0.02 | 0.045 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.056 | 0.031 | 0.056 | Dipeptidyl peptidase inhibitor | |||
| 0.083 | 0.058 | 0.121 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.121 0.024 CID_996 | CID_996 | |
| 0.03 | 0.005 | 0.03 | Neuraminidase (Influenza B) inhibitor | 0.029 0.005 CID_996 | ||
| 0.04 | 0.015 | 0.04 | Carnitine palmitoyltransferase 1 inhibitor | 0.034 0.023 CID_996 | ||
| 0.034 | 0.009 | 0.043 | Sodium/glucose cotransporter inhibitor | 0.043 0.006 CID_996 | CID_996 | |
| 0.098 | 0.073 | 0.165 | Toll-Like receptor 4 antagonist | 0.165 0.014 CID_996 | CID_996 | |
| 0.065 | 0.04 | 0.065 | Acetylcholine M2 receptor antagonist | 0.057 0.047 CID_996 | ||
| 0.04 | 0.016 | 0.04 | Carnitine palmitoyltransferase inhibitor | 0.034 0.024 CID_996 | ||
| 0.029 | 0.005 | 0.029 | Retinoid X beta receptor antagonist | 0.024 0.009 CID_996 | ||
| 0.086 | 0.061 | 0.125 | Interleukin 5 antagonist | 0.125 0.021 CID_996 | CID_996 | |
| 0.044 | 0.02 | 0.044 | Potassium channel KCNQ activator | |||
| 0.044 | 0.02 | 0.044 | Delayed rectifier potassium channel activator | |||
| 0.029 | 0.005 | 0.029 | Factor XIII inhibitor | |||
| 0.033 | 0.008 | 0.033 | Complement factor 1r inhibitor | |||
| 0.028 | 0.004 | 0.028 | Telomerase stimulant | 0.028 0.004 CID_996 | ||
| 0.035 | 0.011 | 0.035 | LFA antagonist | 0.026 0.023 CID_996 | ||
| 0.039 | 0.015 | 0.039 | 5 Hydroxytryptamine 1D agonist | |||
| 0.081 | 0.057 | 0.081 | Ca(v)3.1 blocker | |||
| 0.111 | 0.087 | 0.111 | Acetylcholinesterase inhibitor | 0.107 0.093 CID_996 | ||
| 0.027 | 0.004 | 0.027 | Thromboxane A2 agonist | 0.022 0.005 CID_996 | ||
| 0.042 | 0.019 | 0.042 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.028 | 0.005 | 0.028 | Nicotinic alpha4 receptor agonist | |||
| 0.028 | 0.004 | 0.033 | Antibiotic Anthracycline-like | 0.033 0.003 CID_996 | CID_996 | |
| 0.033 | 0.01 | 0.033 | Prostaglandin H2 antagonist | 0.029 0.014 CID_996 | ||
| 0.035 | 0.013 | 0.035 | CDK4/cyclin D3 inhibitor | 0.027 0.022 CID_996 | ||
| 0.054 | 0.031 | 0.1 | CXC chemokine 1 receptor antagonist | 0.1 0.005 CID_996 | CID_996 | |
| 0.059 | 0.037 | 0.059 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.065 | 0.043 | 0.114 | CDC25B inhibitor | 0.114 0.012 CID_996 | CID_996 | |
| 0.093 | 0.071 | 0.093 | Insulin receptor antagonist | |||
| 0.066 | 0.044 | 0.082 | Leukotriene antagonist | 0.082 0.03 CID_996 | CID_996 | |
| 0.077 | 0.055 | 0.083 | Metalloproteinase-2 inhibitor | 0.083 0.05 CID_996 | CID_996 | |
| 0.06 | 0.038 | 0.06 | Cathepsin L inhibitor | |||
| 0.026 | 0.005 | 0.026 | Complement factor D inhibitor | 0.018 0.013 CID_996 | ||
| 0.047 | 0.025 | 0.047 | Dipeptidyl peptidase IV inhibitor | |||
| 0.025 | 0.003 | 0.025 | Imidazoline I2 receptor antagonist | 0.011 0.008 CID_996 | ||
| 0.029 | 0.008 | 0.029 | ICAM 1 antagonist | 0.026 0.01 CID_996 | ||
| 0.032 | 0.011 | 0.032 | Calcium-sensing receptor agonist | |||
| 0.097 | 0.076 | 0.111 | DNA intercalator | 0.111 0.064 CID_996 | CID_996 | |
| 0.056 | 0.036 | 0.056 | CC chemokine 2 receptor antagonist | |||
| 0.051 | 0.03 | 0.074 | Glycine transporter 2 inhibitor | 0.074 0.019 CID_996 | CID_996 | |
| 0.044 | 0.024 | 0.044 | Plasmepsin II inhibitor | 0.039 0.034 CID_996 | ||
| 0.025 | 0.004 | 0.025 | Methylmalonyl-CoA mutase inhibitor | 0.021 0.007 CID_996 | ||
| 0.105 | 0.085 | 0.659 | Estrogen antagonist | 0.659 0.003 CID_996 | CID_996 | |
| 0.032 | 0.012 | 0.043 | Dopamine autoreceptor agonist | 0.043 0.009 CID_996 | CID_996 | |
| 0.038 | 0.018 | 0.04 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.04 0.016 CID_996 | CID_996 | |
| 0.024 | 0.004 | 0.024 | Glutamate (mGluR6) agonist | 0.022 0.004 CID_996 | ||
| 0.039 | 0.019 | 0.039 | Glucose-dependent insulinotropic receptor agonist | |||
| 0.102 | 0.082 | 0.102 | Activin receptor-like kinase 4 inhibitor | |||
| 0.059 | 0.039 | 0.059 | Calcium channel T-type blocker | |||
| 0.055 | 0.035 | 0.067 | Leukotriene B4 antagonist | 0.067 0.021 CID_996 | CID_996 | |
| 0.042 | 0.023 | 0.042 | G protein-coupled receptor agonist | |||
| 0.041 | 0.022 | 0.041 | Progesterone antagonist | 0.035 0.025 CID_996 | ||
| 0.034 | 0.015 | 0.034 | Elastase 3B inhibitor | |||
| 0.034 | 0.015 | 0.034 | Elastase 2B inhibitor | |||
| 0.034 | 0.015 | 0.034 | Elastase 3A inhibitor | |||
| 0.05 | 0.031 | 0.05 | Glycine transporter inhibitor | |||
| 0.064 | 0.045 | 0.064 | Adenosine A2 receptor antagonist | |||
| 0.022 | 0.004 | 0.022 | Carbonic anhydrase XI inhibitor | |||
| 0.027 | 0.008 | 0.027 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.064 | 0.045 | 0.064 | Cannabinoid receptor agonist | |||
| 0.033 | 0.015 | 0.033 | Thrombin receptor antagonist | |||
| 0.023 | 0.005 | 0.023 | CXC chemokine 5 receptor antagonist | |||
| 0.03 | 0.012 | 0.03 | NMDA receptor glycine site antagonist | 0.03 0.013 CID_996 | ||
| 0.051 | 0.033 | 0.051 | Adenosine A2b receptor antagonist | |||
| 0.055 | 0.038 | 0.1 | Protein kinase C eta inhibitor | 0.1 0.017 CID_996 | CID_996 | |
| 0.046 | 0.028 | 0.058 | Beta adrenoreceptor agonist | 0.058 0.009 CID_996 | CID_996 | |
| 0.024 | 0.006 | 0.04 | Estrogen-related receptor gamma agonist | 0.04 0.003 CID_996 | CID_996 | |
| 0.035 | 0.017 | 0.131 | Estrogen-related receptor beta antagonist | 0.131 0.002 CID_996 | CID_996 | |
| 0.035 | 0.017 | 0.036 | Prostaglandin agonist | 0.036 0.016 CID_996 | CID_996 | |
| 0.079 | 0.062 | 0.079 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.03 | 0.013 | 0.048 | Thyroid hormone agonist | 0.048 0.005 CID_996 | CID_996 | |
| 0.079 | 0.062 | 0.079 | Phosphodiesterase IV inhibitor | |||
| 0.037 | 0.02 | 0.051 | RNA-directed RNA polymerase inhibitor | 0.051 0.013 CID_996 | CID_996 | |
| 0.029 | 0.013 | 0.029 | Prostaglandin EP2 agonist | 0.029 0.013 CID_996 | ||
| 0.033 | 0.017 | 0.033 | Glutamate (mGluR2) antagonist | |||
| 0.035 | 0.019 | 0.035 | Carboxypeptidase B inhibitor | 0.031 0.027 CID_996 | ||
| 0.069 | 0.053 | 0.069 | Telomerase inhibitor | |||
| 0.039 | 0.023 | 0.048 | Kinesin-like protein 1 inhibitor | 0.048 0.017 CID_996 | CID_996 | |
| 0.039 | 0.023 | 0.048 | Kinesin antagonist | 0.048 0.017 CID_996 | CID_996 | |
| 0.027 | 0.011 | 0.027 | Kainate receptor 1 antagonist | 0.018 0.017 CID_996 | ||
| 0.027 | 0.011 | 0.027 | Geranylgeranyltransferase inhibitor | |||
| 0.08 | 0.064 | 0.08 | Transforming growth factor beta 3 antagonist | |||
| 0.028 | 0.013 | 0.091 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.091 0.004 CID_996 | CID_996 | |
| 0.071 | 0.055 | 0.125 | CDC25A inhibitor | 0.125 0.018 CID_996 | CID_996 | |
| 0.036 | 0.02 | 0.036 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.021 | 0.006 | 0.021 | Purinergic P2Y1 agonist | 0.02 0.007 CID_996 | ||
| 0.023 | 0.008 | 0.023 | Toll-Like receptor 8 agonist | |||
| 0.042 | 0.027 | 0.042 | Nicotinic acid receptor 1 agonist | |||
| 0.037 | 0.022 | 0.038 | Calcitonin receptor agonist | 0.038 0.021 CID_996 | CID_996 | |
| 0.033 | 0.018 | 0.033 | AMPA 1 receptor antagonist | 0.032 0.019 CID_996 | ||
| 0.044 | 0.03 | 0.044 | Stearoyl-CoA desaturase inhibitor | |||
| 0.034 | 0.019 | 0.034 | Vanilloid 4 antagonist | |||
| 0.051 | 0.037 | 0.079 | Glucose-6-phosphate translocase inhibitor | 0.079 0.011 CID_996 | CID_996 | |
| 0.034 | 0.02 | 0.034 | ATR kinase inhibitor | |||
| 0.035 | 0.021 | 0.035 | Calcium release-activated channel blocker | |||
| 0.026 | 0.012 | 0.026 | 5 Hydroxytryptamine 4 agonist | |||
| 0.018 | 0.005 | 0.018 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.129 | 0.115 | 0.129 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.021 | 0.007 | 0.021 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.018 | 0.004 | 0.018 | Cyclin D2 inhibitor | 0.013 0.011 CID_996 | ||
| 0.021 | 0.008 | 0.029 | Ileal bile acid transport inhibitor | 0.029 0.005 CID_996 | CID_996 | |
| 0.112 | 0.098 | 0.353 | Interleukin 4 antagonist | 0.353 0.006 CID_996 | CID_996 | |
| 0.067 | 0.055 | 0.067 | Alpha 1b adrenoreceptor antagonist | |||
| 0.04 | 0.028 | 0.04 | Acid-sensing ion channel blocker | |||
| 0.031 | 0.018 | 0.031 | Cyclin E2 inhibitor | |||
| 0.097 | 0.084 | 0.105 | Multidrug resistance-associated protein 1 inhibitor | 0.105 0.07 CID_996 | CID_996 | |
| 0.015 | 0.003 | 0.015 | DNA topoisomerase III inhibitor | 0.01 0.004 CID_996 | ||
| 0.023 | 0.011 | 0.023 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.02 | 0.007 | 0.02 | CC chemokine 9 receptor antagonist | |||
| 0.063 | 0.051 | 0.063 | Matrix metalloproteinase inhibitor | 0.063 0.051 CID_996 | ||
| 0.022 | 0.01 | 0.022 | Histamine H4 receptor agonist | |||
| 0.016 | 0.004 | 0.016 | Progesterone receptor A antagonist | 0.012 0.005 CID_996 | ||
| 0.036 | 0.024 | 0.036 | Glutamate (mGluR8) antagonist | |||
| 0.047 | 0.036 | 0.047 | Metalloproteinase-3 inhibitor | |||
| 0.047 | 0.036 | 0.047 | Sigma receptor antagonist | |||
| 0.061 | 0.05 | 0.061 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.079 | 0.068 | 0.079 | Insulin growth factor antagonist | |||
| 0.018 | 0.007 | 0.018 | CDK2/cyclin A3 inhibitor | |||
| 0.06 | 0.049 | 0.06 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.053 | 0.042 | 0.053 | Matrix metalloproteinase (membrane-type) inhibitor | 0.049 0.047 CID_996 | ||
| 0.039 | 0.028 | 0.039 | Cathepsin L1 inhibitor | |||
| 0.064 | 0.053 | 0.197 | Potassium channel large-conductance Ca-activated activator | 0.197 0.007 CID_996 | CID_996 | |
| 0.074 | 0.064 | 0.074 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.015 | 0.005 | 0.015 | Thromboxane agonist | 0.013 0.005 CID_996 | ||
| 0.032 | 0.021 | 0.045 | HCV NS5B polymerase inhibitor | 0.045 0.012 CID_996 | CID_996 | |
| 0.028 | 0.018 | 0.028 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.019 CID_996 | ||
| 0.09 | 0.08 | 0.09 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.024 | 0.013 | 0.024 | Adenosine kinase inhibitor | |||
| 0.045 | 0.035 | 0.045 | Benzodiazepine inverse agonist | |||
| 0.052 | 0.042 | 0.052 | Pim-2 kinase inhibitor | |||
| 0.06 | 0.051 | 0.065 | Prolactin release inhibitor | 0.065 0.033 CID_996 | CID_996 | |
| 0.074 | 0.064 | 0.074 | Histamine H1 receptor antagonist | |||
| 0.021 | 0.012 | 0.021 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.021 0.012 CID_996 | ||
| 0.014 | 0.006 | 0.017 | Egl nine homolog 3 inhibitor | 0.017 0.005 CID_996 | CID_996 | |
| 0.036 | 0.028 | 0.036 | Melanocortin 1 antagonist | |||
| 0.014 | 0.005 | 0.014 | Melatonin 2 antagonist | |||
| 0.017 | 0.008 | 0.017 | CXC chemokine 4 receptor agonist | |||
| 0.024 | 0.015 | 0.025 | Prostaglandin E2 agonist | 0.025 0.014 CID_996 | CID_996 | |
| 0.033 | 0.025 | 0.038 | Protein kinase C beta I inhibitor | 0.038 0.012 CID_996 | CID_996 | |
| 0.076 | 0.068 | 0.076 | Insulin like growth factor 1 antagonist | |||
| 0.017 | 0.009 | 0.017 | Adenosine A2a receptor agonist | 0.016 0.01 CID_996 | ||
| 0.096 | 0.088 | 0.096 | CDC-like kinase 3 inhibitor | |||
| 0.02 | 0.013 | 0.02 | 5-Alpha-reductase 2 inhibitor | 0.019 0.014 CID_996 | ||
| 0.018 | 0.01 | 0.018 | G-protein-coupled receptor 120 agonist | |||
| 0.02 | 0.013 | 0.02 | Caspase 8 inhibitor | 0.02 0.013 CID_996 | ||
| 0.017 | 0.01 | 0.017 | Adenosine A2 receptor agonist | 0.017 0.01 CID_996 | ||
| 0.099 | 0.091 | 0.099 | TRKA antagonist | |||
| 0.079 | 0.072 | 0.079 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.036 | 0.029 | 0.036 | DNA gyrase subunit B inhibitor | |||
| 0.14 | 0.133 | 0.177 | P-glycoprotein inhibitor | 0.177 0.083 CID_996 | CID_996 | |
| 0.075 | 0.068 | 0.075 | Neuropeptide Y antagonist | |||
| 0.019 | 0.012 | 0.019 | Aminopeptidase A inhibitor | 0.017 0.014 CID_996 | ||
| 0.012 | 0.005 | 0.012 | Angiotensin AT2 receptor agonist | |||
| 0.081 | 0.075 | 0.1 | ATPase (Vacuolar H+) inhibitor | 0.1 0.04 CID_996 | CID_996 | |
| 0.033 | 0.027 | 0.033 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.066 | 0.059 | 0.105 | Lipase inhibitor | 0.105 0.025 CID_996 | CID_996 | |
| 0.053 | 0.046 | 0.053 | Alpha 1d adrenoreceptor antagonist | |||
| 0.01 | 0.003 | 0.01 | CC chemokine 6 receptor agonist | |||
| 0.016 | 0.01 | 0.016 | Prostaglandin EP4 agonist | 0.013 0.011 CID_996 | ||
| 0.049 | 0.043 | 0.049 | Cannabinoid CB2 receptor agonist | |||
| 0.041 | 0.035 | 0.041 | 5 Hydroxytryptamine 2C agonist | |||
| 0.053 | 0.047 | 0.089 | Adenine nucleotide translocase inhibitor | 0.089 0.006 CID_996 | CID_996 | |
| 0.015 | 0.009 | 0.015 | Angiotensin AT1B receptor antagonist | |||
| 0.012 | 0.007 | 0.012 | Purine nucleoside phosphorylase inhibitor | 0.011 0.009 CID_996 | ||
| 0.013 | 0.008 | 0.013 | Integrin beta2 antagonist | |||
| 0.067 | 0.061 | 0.067 | Rho-associated kinase I inhibitor | |||
| 0.025 | 0.02 | 0.025 | Sigma 2 receptor antagonist | 0.023 0.021 CID_996 | ||
| 0.017 | 0.012 | 0.017 | 5-Alpha-reductase 1 inhibitor | |||
| 0.011 | 0.006 | 0.011 | Purinergic P2Y2 agonist | 0.01 0.008 CID_996 | ||
| 0.047 | 0.042 | 0.047 | H+/K+-transporting ATPase inhibitor | |||
| 0.008 | 0.004 | 0.008 | Integrin alpha5beta6 antagonist | 0.007 0.005 CID_996 | ||
| 0.032 | 0.028 | 0.269 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.269 0.003 CID_996 | CID_996 | |
| 0.054 | 0.051 | 0.054 | Dopamine D3 antagonist | |||
| 0.071 | 0.068 | 0.071 | Chymotrypsin inhibitor | |||
| 0.04 | 0.037 | 0.04 | Alpha 1L adrenoreceptor agonist | |||
| 0.018 | 0.015 | 0.018 | Apolipoprotein B inhibitor | |||
| 0.045 | 0.042 | 0.051 | Matrix metalloproteinase 1 inhibitor | 0.051 0.038 CID_996 | CID_996 | |
| 0.096 | 0.093 | 0.1 | Electron transport complex I inhibitor | 0.1 0.083 CID_996 | CID_996 | |
| 0.092 | 0.09 | 0.092 | Factor V inhibitor | |||
| 0.016 | 0.013 | 0.016 | Vitamin D receptor agonist | 0.016 0.012 CID_996 | ||
| 0.048 | 0.046 | 0.188 | NMDA 2B receptor antagonist | 0.188 0.006 CID_996 | CID_996 | |
| 0.065 | 0.062 | 0.065 | Vanilloid antagonist | |||
| 0.009 | 0.007 | 0.009 | Corticotropin releasing factor antagonist | |||
| 0.057 | 0.056 | 0.057 | Fibroblast growth factor 2 antagonist | |||
| 0.005 | 0.003 | 0.005 | Reverse transcriptase (HBV) inhibitor | |||
| 0.014 | 0.012 | 0.018 | Egl nine homolog 1 inhibitor | 0.018 0.007 CID_996 | CID_996 | |
| 0.03 | 0.028 | 0.03 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.045 | 0.043 | 0.045 | Dopamine D4 agonist | |||
| 0.048 | 0.047 | 0.048 | 5 Hydroxytryptamine 1B agonist | |||
| 0.021 | 0.019 | 0.022 | CYP24 inhibitor | 0.022 0.017 CID_996 | CID_996 | |
| 0.013 | 0.012 | 0.013 | Melatonin receptor 1A antagonist | |||
| 0.023 | 0.022 | 0.023 | Prostaglandin EP4 antagonist | |||
| 0.004 | 0.003 | 0.004 | Human herpesvirus 2 protease inhibitor | |||
| 0.02 | 0.019 | 0.02 | Alpha 1a adrenoreceptor agonist | |||
| 0.078 | 0.078 | 0.079 | Hematopoietic | 0.079 0.075 CID_996 | CID_996 | |
| 0.054 | 0.053 | 0.054 | Cyclin A2 inhibitor | |||
| 0.017 | 0.016 | 0.019 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.019 0.014 CID_996 | CID_996 | |
| 0.005 | 0.005 | 0.007 | Transcortin receptor antagonist | 0.007 0.003 CID_996 | CID_996 | |
| 0.153 | 0.153 | 0.268 | Vasodilator | 0.268 0.06 CID_996 | CID_996 | |
| 0.157 | 0.157 | 0.607 | Antioxidant | 0.607 0.011 CID_996 | CID_996 | |
| 0.024 | 0.027 | 0.026 | Glucagon receptor antagonist | 0.026 0.024 CID_996 | CID_996 | |
| 0.116 | 0.118 | 0.167 | Insulin secretagoues | 0.167 0.059 CID_996 | CID_996 | |
| 0.029 | 0.033 | 0.038 | Protein kinase C beta II inhibitor | 0.038 0.014 CID_996 | CID_996 | |
| 0.106 | 0.11 | 0.133 | Histone deacetylase SIRT1 inhibitor | 0.133 0.077 CID_996 | CID_996 | |
| 0.006 | 0.01 | 0.012 | Thyroid hormone beta agonist | 0.012 0.004 CID_996 | CID_996 | |
| 0.081 | 0.085 | 0.096 | ABCA1 expression enhancer | 0.096 0.055 CID_996 | CID_996 | |
| 0.019 | 0.024 | 0.028 | Beta 1 adrenoreceptor agonist | 0.028 0.009 CID_996 | CID_996 | |
| 0.024 | 0.032 | 0.04 | Liver X receptor alpha antagonist | 0.04 0.009 CID_996 | CID_996 | |
| 0.023 | 0.034 | 0.041 | Liver X receptor antagonist | 0.041 0.013 CID_996 | CID_996 | |
| 0.012 | 0.023 | 0.015 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.015 0.01 CID_996 | CID_996 | |
| 0.095 | 0.107 | 0.205 | Tubulin antagonist | 0.205 0.035 CID_996 | CID_996 | |
| 0.054 | 0.066 | 0.08 | Cyclin B3 inhibitor | 0.08 0.038 CID_996 | CID_996 | |
| 0.042 | 0.055 | 0.125 | Maillard reaction inhibitor | 0.125 0.009 CID_996 | CID_996 | |
| 0.041 | 0.056 | 0.18 | Alpha tubulin antagonist | 0.18 0.007 CID_996 | CID_996 | |
| 0.077 | 0.092 | 0.2 | Uric acid excretion stimulant | 0.2 0.013 CID_996 | CID_996 | |
| 0.029 | 0.045 | 0.072 | Dopamine D5 antagonist | 0.072 0.014 CID_996 | CID_996 | |
| 0.04 | 0.058 | 0.163 | Beta tubulin antagonist | 0.163 0.011 CID_996 | CID_996 | |
| 0.058 | 0.077 | 0.274 | Topoisomerase II alpha inhibitor | 0.274 0.009 CID_996 | CID_996 | |
| 0.087 | 0.105 | 0.108 | Histone deacetylase class III inhibitor | 0.108 0.081 CID_996 | CID_996 | |
| 0.056 | 0.077 | 0.126 | Histone deacetylase SIRT1 stimulant | 0.126 0.015 CID_996 | CID_996 | |
| 0.056 | 0.077 | 0.126 | Histone deacetylase stimulant | 0.126 0.015 CID_996 | CID_996 | |
| 0.131 | 0.152 | 0.32 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.32 0.044 CID_996 | CID_996 | |
| 0.043 | 0.065 | 0.072 | Vanilloid 2 antagonist | 0.072 0.013 CID_996 | CID_996 | |
| 0.053 | 0.075 | 0.076 | Sirtuin 1 inhibitor | 0.076 0.039 CID_996 | CID_996 | |
| 0.03 | 0.054 | 0.035 | Glucose-6-phosphate dehydrogenase inhibitor | 0.035 0.031 CID_996 | CID_996 | |
| 0.023 | 0.048 | 0.128 | Catechol O-methyltransferase inhibitor | 0.128 0.004 CID_996 | CID_996 | |
| 0.002 | 0.03 | 0.006 | Insulin like growth factor 3 antagonist | 0.006 0.004 CID_996 | CID_996 | |
| 0.107 | 0.136 | 0.259 | Farnesoid X receptor antagonist | 0.259 0.01 CID_996 | CID_996 | |
| 0.045 | 0.075 | 0.246 | HIV-1 integrase (3'-Processing) inhibitor | 0.246 0.007 CID_996 | CID_996 | |
| 0.047 | 0.078 | 0.06 | Prostaglandin F2 alpha antagonist | 0.06 0.046 CID_996 | CID_996 | |
| 0.079 | 0.111 | 0.383 | Chelator | 0.383 0.006 CID_996 | CID_996 | |
| 0.116 | 0.15 | 0.222 | Platelet adhesion inhibitor | 0.222 0.06 CID_996 | CID_996 | |
| 0.128 | 0.162 | 0.294 | Dyrk kinase inhibitor | 0.294 0.055 CID_996 | CID_996 | |
| 0.011 | 0.049 | 0.017 | Antibiotic Tetracycline-like | 0.017 0.006 CID_996 | CID_996 | |
| 0.04 | 0.08 | 0.125 | Dopamine agonist | 0.125 0.019 CID_996 | CID_996 | |
| 0.045 | 0.085 | 0.119 | Leukotriene synthesis inhibitor | 0.119 0.017 CID_996 | CID_996 | |
| 0.03 | 0.071 | 0.153 | Aldose reductase inhibitor | 0.153 0.01 CID_996 | CID_996 | |
| 0.036 | 0.078 | 0.22 | HIV-1 integrase (Strand Transfer) inhibitor | 0.22 0.008 CID_996 | CID_996 | |
| 0.009 | 0.053 | 0.371 | Estrogen receptor alpha agonist | 0.371 0.003 CID_996 | CID_996 | |
| 0.039 | 0.083 | 0.065 | Factor III inhibitor | 0.065 0.014 CID_996 | CID_996 | |
| 0.069 | 0.114 | 0.131 | Vanilloid agonist | 0.131 0.014 CID_996 | CID_996 | |
| 0.054 | 0.1 | 0.122 | Somatostatin 1 agonist | 0.122 0.022 CID_996 | CID_996 | |
| 0.018 | 0.065 | 0.072 | Estrogen-related receptor alpha antagonist | 0.072 0.009 CID_996 | CID_996 | |
| 0.098 | 0.147 | 0.26 | Protein-tyrosine phosphatase inhibitor | 0.26 0.028 CID_996 | CID_996 | |
| 0.012 | 0.06 | 0.023 | Leukotriene B4 receptor 2 antagonist | 0.023 0.014 CID_996 | CID_996 | |
| 0.033 | 0.083 | 0.054 | Cyclin B2 inhibitor | 0.054 0.041 CID_996 | CID_996 | |
| 0.021 | 0.074 | 0.103 | Dopamine D2 agonist | 0.103 0.01 CID_996 | CID_996 | |
| 0.085 | 0.139 | 0.42 | Lipid peroxidase inhibitor | 0.42 0.009 CID_996 | CID_996 | |
| 0.008 | 0.064 | 0.44 | Estrogen receptor beta agonist | 0.44 0.003 CID_996 | CID_996 | |
| 0.029 | 0.088 | 0.072 | Plasminogen activator inhibitor antagonist | 0.072 0.018 CID_996 | CID_996 | |
| 0.019 | 0.079 | 0.514 | Estrogen agonist | 0.514 0.003 CID_996 | CID_996 | |
| 0.008 | 0.069 | 0.019 | Thyroid hormone alpha agonist | 0.019 0.008 CID_996 | CID_996 | |
| 0.01 | 0.073 | 0.026 | Leukotriene B4 receptor 1 antagonist | 0.026 0.021 CID_996 | CID_996 | |
| 0.109 | 0.172 | 0.377 | Interleukin antagonist | 0.377 0.034 CID_996 | CID_996 | |
| 0.063 | 0.128 | 0.087 | Transcription factor NF kappa B stimulant | 0.087 0.056 CID_996 | CID_996 | |
| 0.073 | 0.137 | 0.142 | Nav1.4 sodium channel blocker | 0.142 0.037 CID_996 | CID_996 | |
| 0.088 | 0.154 | 0.142 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.142 0.081 CID_996 | CID_996 | |
| 0.007 | 0.073 | 0.022 | Estrone sulfatase inhibitor | 0.022 0.014 CID_996 | CID_996 | |
| 0.016 | 0.083 | 0.045 | Nicotinic acid receptor 2 agonist | 0.045 0.016 CID_996 | CID_996 | |
| 0.056 | 0.123 | 0.174 | Antineoplastic alkaloid | 0.174 0.021 CID_996 | CID_996 | |
| 0.011 | 0.078 | 0.044 | Dopamine D1 agonist | 0.044 0.005 CID_996 | CID_996 | |
| 0.044 | 0.112 | 0.062 | Lipocortins synthesis agonist | 0.062 0.031 CID_996 | CID_996 | |
| 0.102 | 0.173 | 0.308 | Nitric oxide antagonist | 0.308 0.039 CID_996 | CID_996 | |
| 0.052 | 0.128 | 0.229 | Opioid kappa receptor antagonist | 0.229 0.008 CID_996 | CID_996 | |
| 0.063 | 0.138 | 0.323 | Topoisomerase II inhibitor | 0.323 0.015 CID_996 | CID_996 | |
| 0.029 | 0.105 | 0.091 | Purinergic P2X2 antagonist | 0.091 0.034 CID_996 | CID_996 | |
| 0.043 | 0.12 | 0.175 | Analgesic, opioid | 0.175 0.011 CID_996 | CID_996 | |
| 0.007 | 0.085 | 0.023 | Thyroid hormone alpha antagonist | 0.023 0.006 CID_996 | CID_996 | |
| 0.089 | 0.167 | 0.259 | Mcl-1 antagonist | 0.259 0.033 CID_996 | CID_996 | |
| 0.046 | 0.128 | 0.167 | HIV-1 integrase inhibitor | 0.167 0.006 CID_996 | CID_996 | |
| 0.019 | 0.102 | 0.047 | Erythropoietin receptor agonist | 0.047 0.023 CID_996 | CID_996 | |
| 0.021 | 0.105 | 0.036 | Tubulin agonist | 0.036 0.021 CID_996 | CID_996 | |
| 0.056 | 0.143 | 0.098 | Aminoacyl-tRNA synthetase inhibitor | 0.098 0.047 CID_996 | CID_996 | |
| 0.014 | 0.104 | 0.074 | Opioid delta receptor agonist | 0.074 0.007 CID_996 | CID_996 | |
| 0.068 | 0.159 | 0.235 | Bone formation stimulant | 0.235 0.028 CID_996 | CID_996 | |
| 0.049 | 0.141 | 0.229 | Opioid antagonist | 0.229 0.01 CID_996 | CID_996 | |
| 0.054 | 0.146 | 0.204 | Protein-tyrosine phosphatase 1B inhibitor | 0.204 0.028 CID_996 | CID_996 | |
| 0.049 | 0.144 | 0.249 | Topoisomerase I inhibitor | 0.249 0.017 CID_996 | CID_996 | |
| 0.062 | 0.157 | 0.204 | DNA polymerase I inhibitor | 0.204 0.027 CID_996 | CID_996 | |
| 0.051 | 0.148 | 0.16 | Bronchodilator | 0.16 0.028 CID_996 | CID_996 | |
| 0.041 | 0.139 | 0.056 | Gonadotropin-releasing hormone receptor agonist | 0.056 0.047 CID_996 | CID_996 | |
| 0.011 | 0.113 | 0.032 | Protocollagen prolyl hydroxylase inhibitor | 0.032 0.013 CID_996 | CID_996 | |
| 0.026 | 0.134 | 0.202 | Opioid mu receptor antagonist | 0.202 0.009 CID_996 | CID_996 | |
| 0.109 | 0.219 | 0.162 | Tumour necrosis factor alpha release inhibitor | 0.162 0.142 CID_996 | CID_996 | |
| 0.026 | 0.14 | 0.045 | DNA gyrase subunit A inhibitor | 0.045 0.024 CID_996 | CID_996 | |
| 0.021 | 0.136 | 0.215 | Opioid delta receptor antagonist | 0.215 0.009 CID_996 | CID_996 | |
| 0.018 | 0.135 | 0.116 | Opioid agonist | 0.116 0.011 CID_996 | CID_996 | |
| 0.092 | 0.21 | 0.246 | Hepatoprotectant | 0.246 0.044 CID_996 | CID_996 | |
| 0.015 | 0.134 | 0.071 | Opioid kappa receptor agonist | 0.071 0.014 CID_996 | CID_996 | |
| 0.007 | 0.127 | 0.015 | Integrin beta6 antagonist | 0.015 0.009 CID_996 | CID_996 | |
| 0.014 | 0.143 | 0.14 | Opioid mu receptor agonist | 0.14 0.008 CID_996 | CID_996 | |
| 0.114 | 0.248 | 0.376 | Hypoglycemic | 0.376 0.032 CID_996 | CID_996 | |
| 0.052 | 0.19 | 0.177 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.177 0.049 CID_996 | CID_996 | |
| 0.067 | 0.216 | 0.313 | Angiogenesis stimulant | 0.313 0.044 CID_996 | CID_996 | |
| 0.131 | 0.284 | 0.289 | Immunosuppressant | 0.289 0.122 CID_996 | CID_996 | |
| 0.021 | 0.179 | 0.063 | Selectin antagonist | 0.063 0.047 CID_996 | CID_996 | |
| 0.078 | 0.242 | 0.149 | Antimitotic | 0.149 0.122 CID_996 | CID_996 | |
| 0.02 | 0.191 | 0.047 | Neurotensin receptor antagonist | 0.047 0.03 CID_996 | CID_996 | |
| 0.08 | 0.256 | 0.178 | Hypolipemic | 0.178 0.111 CID_996 | CID_996 | |
| 0.05 | 0.239 | 0.153 | Thrombolytic | 0.153 0.08 CID_996 | CID_996 | |
| 0.015 | 0.223 | 0.093 | Antineoplastic antibiotic | 0.093 0.049 CID_996 | CID_996 | |
| 0.019 | 0.257 | 0.091 | Neuraminidase (influenza) inhibitor | 0.091 0.019 CID_996 | CID_996 | |
| 0.012 | 0.264 | 0.077 | Neuraminidase inhibitor | 0.077 0.027 CID_996 | CID_996 | |
| 0.119 | 0.479 | 0.428 | Antiinflammatory | 0.428 0.122 CID_996 | CID_996 | |
| 0.005 | 0.38 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.015 CID_996 | CID_996 | |
| 0.076 | 0.547 | 0.305 | Cyclophilin D inhibitor | 0.305 0.158 CID_996 | CID_996 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |